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Abstract
African Americans are disproportionately affected by diabetes mellitus (DM) and
complications that include diabetic retinopathy and its disease and socioeconomic
burdens. This study examined the relationships between diabetic retinopathy and health
care utilization factors, such as gender, DM comorbidities of hypertension and
hyperlipidemia, and health care access, among sampled African Americans with DM in
the United States. The Andersen health care utilization model was the framework for the
study. In this correlational cross-sectional study, data from the 2011-2016 National
Health and Nutrition Examination Survey datasets were analyzed. Results of complex
samples logistic regression showed that there were no significant associations between
diabetic retinopathy and DM comorbidities of hypertension and hyperlipidemia, gender,
and health care access, after controlling for hemoglobin A1C level, urine albumin-tocreatinine ratio (UACR), marital status, education level, and annual household income.
UACR, annual household income, and adult education level were significantly associated
with diabetic retinopathy (p <.005). Researchers might use findings from this study for
further studies to establish cause-and-effect relationships between diabetic retinopathy
and the related health utilization factors in this population. Positive social change might
be effected by using results from the study in planning and developing effective public
health interventions targeting specific African American populations, which might result
in a reduction of the associated physical and socioeconomic burdens on these
populations.
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Section 1: Foundation of the Study and Literature Review
Introduction
Diabetes mellitus (DM) is a disorder of metabolism characterized by chronic
hyperglycemia due to defective insulin action, secretion, or both (American Diabetes
Association [ADA], 2018; Chawla, Chawla, & Jaggi, 2016; World Health Organization
[WHO], 2018). DM is commonly classified as Type 1 (T1DM) and Type 2 (T2DM)
based on age and insulin requirements, with T1DM patients requiring insulin for sugar
control and T2DM patients usually managed with lifestyle modification and oral
medications, though parenteral insulin administration may be required for some cases
(ADA, 2018; Punthakee, Goldenberg, & Katz, 2018; Shields et al., 2015; Skyler et al.,
2017; Yan, Li, Qin, Mayberry, & Daniels, 2018). T1DM results from defective insulin
secretion, whereas T2DM, the most prevalent type of DM globally, is usually seen in
adults and occurs due to insulin resistance or decreased insulin secretion (ADA, 2018;
WHO, 2018). A common clinical feature of DM, irrespective of its type, is chronic
hyperglycemia that results from defective insulin secretion, insulin resistance, or both,
which leads to continuous hyperglycemia and increasing insufficiency of insulin with
time (ADA, 2018; Chawla et al., 2016; Okur, Karantas, & Siafaka, 2017; Punthakee et
al., 2018; Shields et al., 2015; Skyler et al., 2017; Zaccardi, Webb, Yates, & Davies,
2016). Etiologic factors for DM pathophysiology (defective insulin secretion, insulin
resistance or both, with resultant hyperglycemia) include genetics, age, race and
ethnicity, gender, hyperlipidemia, hypertension, unhealthy diet, sedentary lifestyle,
overweight and obesity, smoking, alcohol use, and socioeconomic status (ADA, 2018;
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Baynes, 2015; Centers for Disease Control and Prevention [CDC], 2017; Skyler et al.,
2017).
Uncontrolled DM, irrespective of its type, can lead to macrovascular (large
vessel) disease affecting the heart and arteries, and microvascular (small vessel) disease
affecting the eyes, kidneys and nerves (Beckman & Creager, 2016; Chawla et al., 2016;
Ozawa, Bearse, & Adams, 2015; Solomon et al., 2017; WHO, 2018). DM is associated
with concordant comorbidities, such as hypertension and hyperlipidemia, that are major
intermediate factors in the development of macro- and microvascular diseases
(Abdulghani, et al., 2018; Atchison & Barkmeier, 2016; Beckman & Creager, 2016;
Cheng et al., 2014; Klimek, Kautzky-Willer, Chmiel, Schiller-Frühwirth, & Thurner,
2015; Lin, Kent, Winn, Cohen, & Neumann, 2015; Magnan et al., 2015; Mozaffarian et
al., 2016; Pantalone et al., 2015; Romero-Aroca et al., 2016; Rosiek et al., 2016; Solomon
et al., 2017; Wat, Wong, & Wong, 2016; Zhuo et al., 2014).
DM is currently diagnosed in about 23.1 million adults in the United States; 90%
to 95% of adults living with diabetes have Type 2 DM (CDC, 2017b). Adult African
Americans are disproportionately affected by DM, with a total percentage of 13.4%
compared to 7.4% among Whites (ADA, 2018; CDC, 2017b). There was an increase in
the prevalence of coexisting diabetes, hypertension, and hypercholesterolemia among
U.S. adults from 3% in 1999–2000 to 6.3% in 2011–2012; higher among African
Americans (10.2%), compared to Mexican Americans (6.1 %), other Hispanics (6.6%),
Whites (5.6%), and 7.3% among other racial and ethnic groups (Song et al., 2016). DM
concordant comorbidities, such as hypertension and hyperlipidemia, are major
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intermediate factors underlying cardiovascular disease such as diabetic retinopathy
disparities of African-American populations (Beckman & Creager, 2016; Lin et al., 2015;
Magnan et al., 2015; Mozaffarian et al., 2016; Pantalone et al., 2015; Rosiek et al., 2016;
WHO, 2018; Zhuo et al., 2014). Chronic complications of diabetes, hyperlipidemia, and
hypertension are associated with increased physical, mental, and socioeconomic burdens
on populations, especially African Americans, who are disproportionately affected (Lang,
& Marković, 2016; Lin et al., 2015).
Diabetic retinopathy occurs when chronic high levels of blood glucose cause
damage to blood vessels in the retina, which can lead to (a) swelling and leaking, or (b)
closure of the retinal blood vessels that can prevent passage of blood through the blocked
vessels, and (c) new blood vessel formation in the retina (American Academy of
Ophthalmology, 2018b). It is separated into two main stages that include nonproliferative diabetic retinopathy in the early stage, which may be symptomless, and
proliferative diabetic retinopathy in the late and more advanced stage that may be visionthreatening (American Academy of Ophthalmology, 2018b). Diabetic retinopathy is a
significant cause of preventable eye damage that includes blindness; each year, between
12,000 and 24,000 new cases of blindness are caused by diabetes retinopathy (Skaggs et
al., 2017).
Between 2005 and 2008, the prevalence of non-vision-threatening diabetic
retinopathy and that of vision-threatening diabetic retinopathy among adults 40 years and
older in the United States was 28.5 % and 4.4%, respectively (Zhang et al., 2010).
African American populations are disproportionately affected by diabetic retinopathy
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with a higher crude prevalence of 38.8% compared to 26.4% among Whites, and a higher
vision-threatening retinopathy crude prevalence of 9.3% compared to 3.2% among
Whites (CDC, 2017a; Zhang et al., 2010). Duration of diabetes, uncontrolled
hyperglycemia, and hypertension are common important risk factors for the progression
of diabetic retinopathy to vision-threatening diabetic retinopathy or loss of vision;
glycemic and blood pressure control are effective in preventing diabetic retinopathyrelated loss of vision (Chen et al., 2014; Chew et al., 2010; Do et al., 2015; Lee, Wong, &
Sabanayagam, 2015; Lima, Cavalieri, Lima, Nazario, & Lima, 2016; Mendanha,
Abrahão, Vilar, & Nassaralla, 2016; Romero-Aroca et al., 2016; Ting, Cheung, & Wong,
2016; Wat et al., 2016). Longer duration of diabetes, uncontrolled hyperglycemia,
hypertension, and dyslipidemia are associated with diabetic retinopathy in African
Americans (Papavasileiou et al., 2017; Penman et al., 2016).
Diabetic retinopathy, including its vision-threatening type, is preventable by strict
blood sugar control, control of concordant comorbid conditions (hypertension and
hyperlipidemia), early detection through regular eye-screening of patients with DM, and
prompt management of diabetic retinopathy (ADA, 2018; Chew et al., 2014; Do et al.,
2015; Rosiek et al., 2016; Yu et al., 2015). However, achieving tight control of blood
sugar, hypertension, and hyperlipidemia; early detection through regular eye-screening of
patients with DM; and prompt management of diabetic retinopathy depend on health care
access (ADA, 2018; Chew et al., 2014; Do et al., 2015; Rosiek et al., 2016; Yu et al.,
2015). Strict glycemic control and control of concordant comorbidities depend on selfmanagement skills and activities such as medication adherence, self-monitoring of blood
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glucose, healthy eating, and regular physical activity that are gained through diabetes
self-management education (ADA, 2018; Brunisholz et al., 2014; Chew et al., 2014;
Dirani, Crowston, & vanWijngaarden, 2014; Do et al., 2015; Rosiek et al., 2016; Yu et
al., 2015). Although adult African Americans are disproportionately affected by DM and
diabetic retinopathy, adequate management of the disease—including early detection of
diabetic retinopathy—may be elusive to this population due to racial and ethnic
disparities in health care access in the United States (Hu, Shi, Liang, Haile, & Lee, 2016;
Laiteerapong et al., 2015). There is a need to understand the association between some of
the factors affecting health care utilization and diabetic retinopathy in adult African
Americans with DM.
This research examined the association between health utilization factors of
gender (predisposing), concordant comorbidities of hypertension and hyperlipidemia
(need), health access (enabling), and diabetic retinopathy among sampled adult African
Americans with DM in the United States. I analyzed data from a nationally representative
dataset, the 2011-2016 National Health and Nutrition Examination Survey (NHANES)
dataset (National Center for Health Statistics (NCHS), 2017a). Participants were adult
African Americans with self-reported diabetes. I utilized the Andersen model of health
services use, which purports that predisposing, enabling, and need factors influence
individuals’ health care utilization (Andersen, 1968; Andersen & Newman, 1973). I used
the model in examining the relationships between diabetic retinopathy in African
Americans and the demographic predisposing factor of gender; need factors of DM,
hypertension, and hyperlipidemia, and enabling factors that facilitate health care access
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such as health insurance, availability of preventive, diagnostic services including eye
screening services, and treatment services for DM and its comorbidities; availability of
doctors and diabetes specialists; and geographic accessibility (Andersen, 1968; Andersen
& Newman, 1973). There is a paucity of research on the associations between (a) a
predisposing demographic factor of gender, (b) need factors such as DM comorbidities of
hypertension and hyperlipidemia, and (c) enabling factors of health care access, which
are all determinants of health care utilization and diabetic retinopathy in adult African
Americans with DM in the United States. I conducted this research to identify health
utilization factors associated with diabetic retinopathy that disproportionately affects
adult African Americans with its sight-related functional and socioeconomic burdens.
Through this research, a gap will be filled in literature with the understanding of the
factors mentioned above responsible for diabetic retinopathy disparities in AfricanAmerican populations.
This section includes (in the following order) the problem statement, purpose of
the study, research questions and answers, theoretical foundation of the study, nature of
the study, literature search strategies, literature review related to key variables and
research questions, definitions, assumptions, scope and delimitations, significance,
summary, and conclusions.
Problem Statement
In the United States, African American populations are disproportionately
affected by diabetic retinopathy, which is related to the duration of diabetes, uncontrolled
hyperglycemia, and hypertension (Beckman & Creager, 2016; Lin et al., 2015; Magnan et

7
al., 2015; Mozaffarian et al., 2016; Pantalone et al., 2015; Rosiek et al., 2016; Zhuo et al.,
2014). Diabetic retinopathy can be prevented through strict control of blood sugar,
hypertension, and hyperlipidemia, early detection of diabetic retinopathy through regular
eye-screening of patients with DM, and prompt management of diabetic retinopathy,
which depends on health care utilization that may be elusive to adult African Americans
with DM (Atchison & Barkmeier, 2016; Chen et al., 2014; Chew et al., 2014; Do et al.,
2015; Hu et al., 206; Laiteerapong et al., 2015; Lee et al., 2015; Lima et al., 2016;
Mendanha et al., 2016; Romero-Aroca et al., 2016; Ting et al., 2016; Wat et al., 2016).
There is a dearth of research on the association between (a) predisposing demographic
factor of gender; (b) need factors such as DM comorbidities of hypertension and
hyperlipidemia; and (c) enabling factors of health care access that are determinants of
health care utilization and diabetic retinopathy in adult African Americans in the United
States. This research was informed by the Andersen model of health services use. This
study helps fill the gap in the literature regarding the factors responsible for diabetic
retinopathy disparities in African American populations.
Purpose of the Study
This was a quantitative research study, aimed at investigating the relationships
between health utilization factors such as DM comorbidities, gender, health care access,
and diabetic retinopathy among African Americans. I examined the relationship between
the independent variables of (a) gender, (b) comorbidities of DM (e.g., hypertension
hyperlipidemia), and (c) facilitators of health care access (e.g., current health insurance,
primary care provider, diabetes specialists, and eye screening service) and the dependent
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variable of diabetic retinopathy. Covariates included education level, gender, and marital
status (predisposing factors), annual household income (health care access), and urinary
albumin-creatinine ratio (UACR) and HBA1C (need factors). For this study, I analyzed
data from a nationally representative dataset, the 2011-2016 NHANES dataset.
Research Questions and Hypotheses
Research Question 1: Is there an association between gender and diabetes
retinopathy among adult African Americans in the United States?
Hо1: There is no association between gender and diabetes retinopathy among
adult African Americans in the United States
H₁1: There is an association between gender and diabetes retinopathy among adult
African Americans in the United States.
Research Question 2: Is there an association between DM-related comorbidities of
hypertension, hyperlipidemia, and diabetic retinopathy among adult African American
populations in the United States?
Hо2: There is no association between DM-related comorbidities of hypertension,
hyperlipidemia, and diabetic retinopathy among adult African American populations in
the United States.
H₁2: There is an association between DM-related comorbidities of hypertension,
hyperlipidemia, and diabetic retinopathy among adult African American populations in
the United States.
Research Question 3: Is there an association between health care access and
diabetic retinopathy among adult African Americans in the United States?
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Hо3: There is no association between health care access and diabetic retinopathy
among adult African Americans with DM in the United States.
H₁3: There is an association between health care access and diabetic retinopathy
among adult African Americans with DM in the United States.
Framework for the Study
As a framework for this study, I used the Andersen model of health services use,
which purports that predisposing, enabling, and need factors influence individuals’ health
care utilization (Andersen, 1968; Andersen & Newman, 1973). Predisposing factors are
sociodemographic characteristics, such as age, gender, race/ethnicity, education,
employment, and marital status; need factors are motivators of health care use, including
perceived need by individuals and assessed health status, which includes chronic health;
enabling factors are those factors that facilitate the use of health care services by
individuals, such as household income, availability of health care insurance, having a
regular doctor, availability of needed services, and distance to the health care facility
(Andersen, 1968; Andersen & Newman, 1973). The model is adaptable, and researchers
have widely used it to examine factors that lead to health services utilization in various
settings (Andrej et al., 2016; Brzoska et al., 2017; Hirshfield et al., 2018; Li et al., 2016;
Luo et al., 2018; McClure et al., 2016; Petrovic & Blank, 2015; Tesfaye et al., 2018) The
model is suitable in examining the relationship between the (a) demographic predisposing
factor of gender; (b) enabling factors that facilitate health care access, including health
insurance, availability of preventive and diagnostic services (e.g., eye screening services),
treatment services for DM and comorbidity of hypertension and hyperlipidemia,
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availability of doctors and diabetes specialists, and geographic accessibility; and (c) need
factors that include hypertension, hyperlipidemia, and diabetic retinopathy, which is an
indirect measure of health care utilization in adult African Americans (Andersen, 1968;
Andersen & Newman, 1973).
Nature of the Study
This research was a quantitative, nonexperimental, correlational cross-sectional
study aimed at exploring the relationships between independent variables (i.e., gender,
comorbidities of DM and hypertension, and health care access) and the dependent
variable of diabetic retinopathy among a large sample of adult African Americans in the
United States from 2015 to 2016. Covariates included education level, age group, marital
status, albuminuria, HBA1C level, and income level. Data analyzed in this study were
from a nationally representative dataset, the 2015-2016 NHANES dataset (CDC, 2017a).
Literature Search Strategies
In conducting the literature review, I used academic search engines and databases,
including the Walden University Library search catalog, PubMed, Medline, ProQuest,
Google Scholar, SAGE Journals, ScienceDirect, Thoreau Multi-Database Search,
CINAHL & MEDLINE combined Search, and Cochrane. Criteria for inclusion in the
literature review were primary peer-reviewed research articles on diabetic retinopathy,
risk factors for developing diabetic retinopathy generally and among African Americans,
diabetes comorbidities and diabetic retinopathy, eye care service utilization among adult
African Americans with diabetes, and access to health care in African Americans.
Keyword search emphasized locating articles on Andersen model of health services use,
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and studies informed by the Andersen model of health services use. To find literature on
adult African Americans with diabetes and retinopathy search terms included
comorbidities and retinopathy, perceptions of adult African Americans on diseases,
sociodemographic influence on diabetic retinopathy, access to health care in AfricanAmericans, access to health care in African Americans with DM, access to health care in
African Americans with DM and retinopathy, eye screening service use among adult
diabetics, and screening service utilization among adult African Americans with diabetes.
The selected articles were written in English, peer reviewed, and not older than 2014
except seminal articles on the Andersen model of health services use, which is the
theoretical framework for this research, and articles that filled gaps in the literature. In
addition to the academic search engines, grey literature sources such as non-peerreviewed government and nonprofit publications including the CDC and the Agency for
Healthcare Research and Quality websites were searched for data; the U.S. Department of
Agriculture and U.S. Department of Health and Human Services websites were searched
for dietary practice guidelines; the U.S. Department of Health & Human Services/Office
for Human Research Protections website was also searched for information on basic
health and human services policy on protection of human research participants; and the
ADA and American Academy of Ophthalmologists websites were searched for practice
guidelines and definitions.
Literature Review Related to Key Variables and Concepts
From the literature search, I selected 56 articles that met the inclusion criteria.
Among these articles were critical reviews of the literature related to DM comorbidities

12
and diabetic retinopathy, sociodemographic risk factors for diabetic retinopathy, and
factors that determine health care access among African Americans. The study design for
many of the selected articles was cross-sectional; other study designs used included
longitudinal, prospective, retrospective, randomized clinical trial, case study, quasiexperimental, mixed methods, pre-post, surveys, and systematic reviews. The literature
review is presented according to the framework for this study and key variables of
diabetic retinopathy, gender, DM comorbidities associated with diabetic retinopathy,
health care access, and research questions.
Constructs of the Andersen model of health services use suggest that
predisposing, enabling, and need factors influence individuals’ health care utilization
(Andersen, 1968; Andersen & Newman, 1973). Predisposing factors are
sociodemographic such as age, gender, race/ethnicity, education, employment, household
income, and marital status; need factors are motivators of health care use that include
perceived need by individuals, assessed health status that includes chronic health such as
DM, hypertension, hyperlipidemia, albuminuria, and HBAIC; and enabling factors that
facilitate the use of health care services by individuals such as availability of health care
insurance or ability for out-of-pocket-payment, having a regular doctor, availability of
needed services, and distance to the health care facility (Andersen, 1968; Andersen &
Newman, 1973). The model was developed by Andersen in 1968 but has evolved
(Andersen, 1968; Andersen & Newman, 1973). It has been widely utilized in examining
the factors that lead to health services utilization in various settings (Andrej, Rok, &
Prevolnik, 2016; Brzoska, Erdsiek, & Waury, 2017; Hirshfield et al., 2018; Li et al.,
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2016; Luo et al., 2018; McClure et al., 2016; Petrovic & Blank, 2015; Tesfaye et al.,
2018). For example, Hirshfield et al. (2018) used this model as a framework for a crosssectional study to examine risk factors for developing hypertension among a sample of
7,454 men with male sexual partners in the United States. According to Hirshfield et al.,
even though about a third of U.S. men are living with hypertension, the diagnosis and
management of which depend on health care utilization, there is a dearth of studies on
hypertension among men who have sex with men. The following factors were identified:
predisposing factors of race, age, education, relationship status; need factors such as
perception of being overweight, living with DM, heart disease, stroke, anxiety or
depression; and enabling factors of having a regular doctor, current income, current
health insurance, residence in South Atlantic or South Central; self-report of hypertension
was used as a proxy measure of health care utilization (Hirshfield et al., 2018).
In this research, the Andersen model of health services use is suitable for
examining the associations between the main independent variables and covariates of
sociodemographic predisposing factors, need factors, enabling factors, and the dependent
variable of diabetic retinopathy that is an indirect measure of health care utilization
(Andersen, 1968; Andersen & Newman, 1973).
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Independent Variables
Predisposing factor:
Gender

Need factors:
DM Comorbidities
-Hypertension
-Hyperlipidemia

Enabling factors:
Health care access
-Current health insurance
-Primary care provider
-Diabetes Specialists
-Eye screening service

Dependent Variable:
Diabetic retinopathy
(indirect measure of health
care Utilization)

Covariates:
Education level, Marital status,
(predisposing factors), HBA1C
levels and Urine albumincreatinine ratio (UACR) (need
factor), Household income
(enabling factor)

Figure 1. Conceptual framework for associations between DM comorbidities, gender,
and diabetic retinopathy among adult African Americans with DM.
Diabetic Retinopathy
Diabetic retinopathy is a common DM complication (Lin et al., 2015; Magnan et
al., 2015; Pantalone et al., 2015; Rosiek et al., 2016). Diabetic retinopathy occurs when
chronic high levels of blood glucose cause damage to blood vessels in the retina, which
can lead to (a) swelling and leaking, or (b) closure of the retinal blood vessels that can
prevent passage of blood through the blocked vessels, and (c) new blood vessel formation
in the retina (American Academy of Ophthalmology, 2018b). Diabetic retinopathy is
separated into two main stages that include the early stage, nonproliferative diabetic

15
retinopathy, which affects many individuals with diabetes and may be symptomless, and
proliferative diabetic retinopathy in the late and more advanced stage, which may be
vision-threatening (American Academy of Ophthalmology, 2018b).
In the United States, diabetic retinopathy is the most common microvascular
complication of diabetes and is the primary cause of new cases of blindness among adults
living with diabetes between ages of 20 and 74 years (Jani et al., 2017). Results of a
cross-sectional study (analysis of data from NHANES 2011 - 2014 cycles) conducted by
Shah (2016) suggested that the prevalence of diabetic retinopathy among U.S. adults, 40
years old and over, was 14.7% (95% confidence interval [CI], 11.7–17.8%); prevalence
among males was 16.1% (95% CI, 13.0–19.1%), and among females was 13.4% (95%
CI, 9.2–17.5%). In a cross-sectional study from the analysis of NHANES 2005-2008
data, Zhang et al. (2010) demonstrated diabetic retinopathy prevalence of 28.5% (95%
CI, 24.9–32.5%) and vision-threatening diabetic retinopathy prevalence of 4.4% (95%
CI, 3.5–5.7%), which was higher among adult African Americans compared to Whites
(38.8% versus 26.4%, p = .01), and slightly higher among males than females (31.6%
versus 25.7%, p = .04); independent risk factors were male gender, longer duration of
diabetes, insulin use, higher HBA1C level, and higher systolic blood pressure. Duration
of diabetes, uncontrolled hyperglycemia, and hypertension are common important risk
factors for the progression of diabetic retinopathy to the vision-threatening type or loss of
vision (Atchison & Barkmeier, 2016; Chen et al., 2014; Chew et al., 2014; Do et al.,
2015; Lee et al., 2015; Lima et al., 2016; Mendanha et al., 2016; Romero-Aroca et al.,
2016; Ting et al., 2016; Wat et al., 2016). Longer duration of diabetes, uncontrolled
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hyperglycemia, hypertension, and dyslipidemia are associated with diabetic retinopathy
in adult African Americans (Papavasileiou et al., 2017; Penman et al., 2016).
Diabetic retinopathy is a leading cause of preventable eye damage, which includes
blindness; each year 12,000–24,000 new cases of blindness are caused by diabetic
retinopathy (Skaggs et al., 2017). Diabetic macular edema is a significant cause of sight
loss in 1038 individuals living with DM (Varma et al., 2014). Results of a cross-sectional
study (data from NHANES 2005-2006 and 2007-2008 cycles were analyzed) by Varma
et al. (2014) suggested that African Americans with diabetes have a higher likelihood of
developing diabetic macular edema. Longer duration of diabetes and elevated levels of
HBAIC were associated with its prevalence. As a significant cause of socioeconomic
burden in the United States, results of a cross-sectional study by Willis et al. (2017) on
1004 adults living with diabetes in the United States showed a significant relationship
between sight-related functional burden and types of diabetic retinopathy with high
severity.
There is a need for preventive measures against diabetic retinopathy of high
severity to minimize sight-related functional burden among adults living with diabetes in
the United States because there is a higher likeliness of not being involved in any gainful
employment due to decreased vision (Sherrod et al., 2014; Willis et al., 2017).
Understanding the factors that determine the utilization of treatment and preventive DM
services by adult African Americans with diabetes will be useful for developing
appropriate services. As such, research on the relationships between health care
utilization factors and diabetic retinopathy in this population was necessary.
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Gender
In the United States, there is no significant gender-related difference in the
prevalence of diagnosed DM among adults (CDC, 2017). Systematic reviews by Ozawa
et al. (2015) and Wat et al. (2016) did not demonstrate a strong association between
gender and retinopathy. However, the results of Zhang et al.’s (2010) cross-sectional
study in the United States showed that male gender is an independent risk factor for
diabetic retinopathy. Similar results were obtained from a cross-sectional study among
adult Saudi diabetic patients by Abdulghani et al. (2018), which showed an association
between male gender and diabetic retinopathy. Although there was no statistically
significant difference in diabetic retinopathy incidence in the Los Angeles Latino eye
study, males had a 50% higher risk of having any diabetic retinopathy (OR = 1.50; p =
.006) compared with women as demonstrated by their stepwise multivariate model
(Varma et al., 2007). Similar results were demonstrated by the United Kingdom
prospective diabetes 50 study; there was no difference in diabetic retinopathy rates
between male and female sexes (p = 0.67), but there was a lower risk ratio of diabetic
retinopathy progression in women as shown by a multivariate model (Strutton et al.,
2001).
Review of literature on the relationship between gender and diabetic retinopathy
showed that the association between gender and development of diabetic retinopathy has
not been established. Even though the results of Zhang et al.’s (2010) study on a
representative sample of the United States population suggested that male gender is an
independent risk factor for diabetic retinopathy, the prevalence was higher among Whites
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59.7 %; 95% Cl, 49.5%–69.1%) compared to African Americans (24.0%; 95% Cl,
18.2%–30.8%; p = .008). The cross-sectional design of this study will affect the
generalizability of the result beyond the study population. The study by Penman et al.
(2015) was on adult African Americans with diabetes, but only the results for female
participants was reported and was statistically insignificant (60.3%; p = .27); moreover,
small sample size and purposive sampling design utilized will affect the generalizability
of the results beyond the study population. There was a need to carry out a study on the
association between gender and diabetes retinopathy among adult African American
population on a large sample that is representative of this population.
Comorbidities
DM is associated with concordant comorbidities such as hypertension and
hyperlipidemia that are major risk factors in the development of macro and microvascular
diseases (Abdulghani, et al., 2018; Atchison & Barkmeier, 2016; Beckman & Creager,
2016; Cheng et al., 2014; Klimek et al., 2015; Lin et al., 2015; Magnan et al., 2015;
Mozaffarian et al., 2016; Pantalone et al., 2015; Raum et al., 2015; Romero-Aroca et al.,
2016; Rosiek et al., 2016; Solomon et al., 2017; Song et al., 2016; Wat et al., 2016;
Walraven et al., 2015; Zhuo et al., 2014). Cardio-metabolite risk factors for diabetic
retinopathy include hypertension, hypertriglyceridemia, hypocholesterolemia (HDL), and
abdominal obesity (Cheng et al., 2014). According to the results of a study by Cheng et
al. (2014) in China, diabetic retinopathy prevalence when associated with one, two, three,
and four of the cardio-metabolites was 16.0%, 17.6%, 21.3%, and 25.1%, (p = .001)
respectively. However, results of a prospective cohort study on 759 adult diabetic patients
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(25-75 years) without diabetic retinopathy in Korea (followed up for 11 to 12 years),
suggested that glycemic control, age, and albuminuria were significant risk factors for the
development of diabetic retinopathy (Yun et al., 2016).
DM concordant comorbidities of hypertension and hyperlipidemia are major
intermediate factors underlying cardiovascular disease such as diabetic retinopathy
disparities of African American populations (Beckman & Creager, 2016; Lin et al., 2015;
Magnan et al., 2015; Mozaffarian et al., 2016; Pantalone et al., 2015; Rosiek et al., 2016;
Zhuo et al., 2014). Results of a cross-sectional study (analysis of NHANES data from
1999 to 2012) by Song et al. (2016), showed an increase in the prevalence of coexisting
diabetes, hypertension and hypercholesterolemia among United States adults from 3% in
1999–2000 to 6.3% in 2011–2012 (p < .001). According to Song et al. concordant
comorbidities of DM, hypertension, and hyperlipidemia in 2012 was higher among
African Americans (10.2%, p < .001), compared to Mexican Americans (6.1 %, p =
.020), other Hispanics (6.6%, p = .220), Whites (5.6%, p < .001), and other racial and
ethnic groups (7.3%, p = .450). A study was carried out by Penman et al. (2015) to
examine individual and demographic risk factors for proliferative diabetic retinopathy in
adult African Americans with T2DM. African Americans with Type 2 diabetes (n = 358)
were recruited from four sites in Mississippi and Massachusetts (Penman et al.). The
results demonstrated that longer duration of diabetes (OR, 1.62, p < .001), systolic
hypertension (OR 1.65, p < .001), and insulin treatment (OR 6.65, p < .001) were strong
risk factors for the development of proliferative diabetic retinopathy (Penman et al.).
Although HBA1C was statistically significant in the univariate analysis (OR 1.3, p =
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.002), it was not significant in multivariate analysis (OR 1.04, p = 0.68) (Penman et al).
Total cholesterol (p = 0.42), triglyceride (p = 0.49); LDL cholesterol (p = 0.39); and HDL
cholesterol (p = 0.52), were not statistically significant (Penman et al.).
Hypertension and hyperlipidemia are modifiable diabetes concordant
comorbidities. Several studies have demonstrated that hypertension and hyperlipidemia
have positive associations with the development of diabetic retinopathy (Abdulghani, et
al., 2018; Beckman & Creager, 2016; Cheng et al., 2014; Do et al., 2015; Klimek,
Kautzky-Willer, Chmiel, Schiller-Frühwirth, & Thurner, 2015; Lin et al., 2015; Magnan
et al., 2015; Mozaffarian et al., 2016; Pantalone et al., 2015; Romero-Aroca et al., 2016;
Rosiek et al., 2016; Solomon et al., 2017; Song et al., 2016; Wat et al., 2016; Zhuo et al.,
2014). A meta-analysis by Wang et al. (2015) found a decreased risk of retinopathy of
about 7 %, decreased risk of progression of diabetic retinopathy of about 5%, and an
increased probability of diabetic retinopathy regression in diabetics on renin-angiotensin
system inhibitor. There was a statistically significant decreased risk of diabetic
retinopathy progression (0.84, p =.002), and an increased probability of diabetic
retinopathy regression (1.50, p=.003) in diabetics on treatment with angiotensinconverting enzyme inhibitors; however, there was only an association between the use of
angiotensin receptor blockers and decreased diabetic retinopathy progression (1.32,
p=.008) (Wang et al.). However, the result of a Cochrane review by Do et al. (2015)
showed hypertension treatment can prevent diabetic retinopathy but does not slow its
progression. Results of a Danish study showed that use of statins before diagnosis of DM
was associated with diabetic retinopathy development; its use was also linked to
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improvement in visual acuity in those with diagnosed diabetic retinopathy (Nielsen &
Nordestgaard, 2014).
Researchers have identified comorbidities associated with diabetic retinopathy
and the advanced types of proliferative retinopathy and macular edema. Most of the
studies were on mixed populations with minimal representation of African Americans,
purposive sampling and cross-sectional study designs were mostly used, which will affect
the generalizability of the study results beyond the study populations. There was a need
to identify comorbidities associated with diabetic retinopathy on a large representative
sample of adult African Americans.
Health Care Access
Health care access is the ability to gain entry into or utilize personal health care
service for achieving optimum outcomes in health (HealthyPeople.gov., 2018). Three
steps involved in achieving health care access include (a) getting into the health care
system that is commonly through medical insurance coverage, (b) geographic
accessibility of required health care services, and (c) identifying a trustworthy health care
provider that can be easily communicated with (HealthyPeople.gov., 2018). Prevention of
diabetic retinopathy and its progression to its vision-threatening type depend on health
care access (Atchison & Barkmeier, 2016; Chen et al., 2014; Chew et al., 2014; 2016; Do
et al., 2015; Lee et al., 2015; Lima et al., 2016; Mendanha et al., Romero-Aroca et al.,
2016; Ting et al; Wat et al., 2016).
Obtaining recommended diabetes preventive services is dependent on the status of
medical insurance (Bailey et al., 2016). Bailey et al. (2016) carried out a retrospective
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cohort research to determine any relationship between disparities in diabetes prevention
services obtained and status of medical insurance during health care facility visit.
Medicaid and electronic health record data of study participants from 38 community
health centers in Oregon from 200-2007 were analyzed (Bailey et al.). Study participants
were categorized as patients that were insured throughout the study period (continuously
insured), uninsured throughout the study period (continuously uninsured), and those
without insurance for part of the study period (discontinuously insured). There were
1,466 patients that were insured continuously; 1,117 uninsured continuously; and 336
insured discontinuously (Bailey et al.). Results suggested that patients without continuous
insurance had lower odds of obtaining diabetes prevention services during scheduled
visits compared to patients with continuous insurance (odds ratio = 0 .73, 95% CI =
0.66); and among the patients without insurance for part of the study period, probability
of not obtaining diabetes preventive services due for the scheduled visit was associated
with not being insured at that particular clinic visit (odds ratio =0.77, 95% CI = 0.64)
compared to when insured at the particular clinic visit (Bailey et al.).
Early detection of diabetic retinopathy is of extreme importance in preventing loss
of vision, and timely medical and surgical treatments have dramatically reduced diabetic
retinopathy progression (Jani et al., 2017). The effectiveness of diabetic retinopathy
screening programs depends on how patients adhere to the schedule of follow-up eye
management as recommended by the diabetic retinopathy screening program (Keenum et
al., 2016). Although African Americans are among those at highest risk for diabetic
retinopathy, they had one of the lowest rates of diabetic retinopathy screening and
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scheduled follow-up eye care utilization (Keenum et al., 2016; Maclennan et al., 2014;
Yu et al., 2015). Factors that influence screening include lack of health care access that is
influenced by health insurance coverage, transportation, and accessibility to an eye
specialist, late or non-referrals from primary care physicians, inadequate communication
between primary care physicians and eye specialists, misinformation about diabetic
retinopathy screening, miscommunication about patients’ addresses, patients’ detachment
from diabetes care, and lack of diabetes-management education in those living with
diabetes (Al-Alawi et al., 2016; Chou et al., 2014; Hipwell et al., 2014; Jani et al., 2017;
Kashim et al., 2018; Lindenmeyer et al., 2015; MacLennan et al., 2014; Piyasena et al.,
2019; Spears et al., 2018; Strutton et al., 2016).
In a prospective follow-up study, Keenum et al. (2016) examined the rate of
adherence to recommended follow-up eye care in a diabetic retinopathy screening
program administered in a health care facility that provides access to care irrespective of
the patients’ affordability. Study participants were individuals with Type 1 diabetes or
T2DM receiving care in an internal medicine clinic of a health system with retinopathy
screening program in Alabama that is publicly funded, which serves a predominantly
uninsured African American population (Keenum et al.). Results suggested that after the
diabetic retinopathy screening, only a third of study participants adhered to scheduled
intervals for follow-up eye care despite minimizing accessibility and costs as barriers to
eye care (Keenum et al.). Keenum et al. suggested incorporating eye education strategies
to promote adherence to recommended eye care that can prevent loss of vision from
diabetic retinopathy.
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Telemedicine is an emerging strategy for improving evaluation for diabetic
retinopathy through retinal imaging in the primary care setting with remote interpretation
by an expert (Jani et al., 2017; Mansberger et al., 2015). In the United States, diabetic
retinopathy was identified in 1 out of 5 individuals living with diabetes through a diabetic
retinopathy telemedicine screening offered in urban clinical or pharmacy environments
largely that were mostly utilized by racial and ethnic minorities (Owsley et al., 2015). A
pre- and post-implementation evaluation by Jani et al. (2017) at five primary care clinics
providing health care services to underserved populations in North Carolina showed that
rate of diabetic retinopathy evaluation is increased by retinal telemedicine screening for
diabetic retinopathy in patients in underserved populations; access to care for minorities
and patients with diabetic retinopathy requiring treatment in the primary care setting
might also be increased. With early identification of patients at risk of loss of vision,
retinal telemedicine programs can lead to decreased health care costs and reduce the
socioeconomic burden of vision-threatening visual loss on the society (Jani et al.).
Although health care access plays a vital role in diabetic retinopathy screening,
the quality of services offered may not be equal in all health care institutions due to
disparities in preventive care that are usually provided in primary care encounters. Even
though primary care encounters usually provide opportunities for preventive health care
such as diabetes self-management education (DSME), there are considerable race and
ethnic disparities in preventive care that are usually provided in primary care encounters;
access to quality health care as offered in primary care centers is limited to many African
Americans with diabetes, they rely on government-subsidized and less-resourced
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community health centers located in their residential areas for medical care (Agency for
Healthcare Research and Quality, 2017; Fiscella, K. & Sanders, 2016). Racial and ethnic
disparities exist in quality of care provided for control of chronic noncommunicable
diseases such as hypertension, hyperlipidemia, and diabetes that are risk factors for
diabetic retinopathy, with African Americans and other minority patients having
suboptimal control for blood sugar, blood cholesterol, and blood pressure with resultant
complications that include diabetic retinopathy (Agency for Healthcare Research and
Quality, 2017; Laiteerapong et al., 2015; Yoon et al., 2015). Abramson, Hashemi, and
Sánchez-Jankowski (2015) carried out a cross-sectional study that employed a multi-level
approach to examine perceptions of United States racial health care discrimination and
micro and macro-level factors that influence behaviors, health experiences, and outcomes
among and between racial groups. Data on 43,020 adults between 18 and 85 years from
California's major racial and ethnic groups obtained from the California Health Interview
Survey 2005 were analyzed (Abramson et al.). Results showed that racial minorities,
especially African-Americans reported more racial health care discrimination; increased
perceptions of discrimination were associated with poor communication with health care
provider across all racial and ethnic groups; and perceptions of discrimination were
associated with an increased level of education in all racial and ethnic groups except
Whites (Abramson et al.).
Laiteerapong et al. (2015) carried out a cross-sectional study to determine
disparities in diabetes care. The study sample was a nationally representative sample of
Hispanics, African Americans, and Whites, aged 20 years or over, with self-reported
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diabetes in the NHANES, 2007–2010. There were individualized glycemic goals that
were assigned based on duration, age, duration, comorbidity, and complications; and,
low-density lipoprotein cholesterol goals assigned based on the history of cardiovascular
disease (Laiteerapong et al.). The results showed that more Whites achieved HBA1C <
8% goal than African Americans (81% versus 74%, p < .001); fewer African Americans
were recommended individualized LDL goals compared to Whites (10% versus 33%, p <
.003 ; more Whites (51%) achieved individualized LDL control; and adequate blood
pressure control goal of less than 140/90 mmHg was reached by fewer African
Americans compared to Whites (53% versus 69%, p < .001).
A cross-sectional study was carried out by Assari et al. (2017) on 163 African
Americans with T2DM in outpatient clinic of a large Midwestern urban health care
system to examine dissimilarities in levels of racial health care discrimination perceptions
and the relationship between the perceived discrimination and blood sugar control.
Results demonstrated that racial health care discrimination is reported more by African
American men with T2DM than women with T2DM; perceived discrimination is
associated higher levels of HBA1C in African American men (Assari et al.). Assari et al.
suggested that consideration should be given to gender by clinicians and academics when
the effects of racial health care discrimination on health outcomes are being examined.
Several factors may influence racial disparities in diabetes management services.
Hu et al. (2016) carried out a cross-sectional study to determine the factors that may
influence racial disparities in primary care access and quality in those with diabetes by a
secondary data analysis on 2,617 adults with self-reported T2D derived from the
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household part of the Medical Expenditure Panel Survey of 2012. The results showed that
although there were initial racial and ethnic disparities in the access to primary care and
quality, socioeconomic status is a stronger determinant of access to primary care and
quality and outcomes in those with T2DM than race and ethnicity (Hu et al.). According
to the authors, the policy implication of the result is that policymakers should ensure
equitable health care access and quality to all by focusing on the health care needs of the
underprivileged and underserved populations such as those with lower socioeconomic
status (Hu et al.). In Canada, Bird, Lemstra, Rogers, and Moraros (2015) from a crosssectional study found that household income has a strong and independent association
with the prevalence of T2DM and some concordant comorbidities and physical inactivity.
Relationship between disparities in diabetes prevention services obtained and status of
medical insurance during health care facility visit was suggested by results of a
retrospective cohort research by Bailey et al. (2016); however, the internal and external
validity of the results are compromised by the purposive sampling method used and a
predominantly Hispanic population.
According to results of the study by Ascari et al, (2017), discrimination is
reported more by African American men with T2DM than women with T2DM and
perceived discrimination is associated higher levels of HBA1C in African American men;
however internal and external validity of the results are affected by the cross-sectional
study design and purposive sampling method. Results of studies by Bird et al. (2015) and
Hu et al. (2016) highlighted the intrapersonal and community-level factors that influence
health care access and quality in T2DM patients. Results of the study by Hu et al. (2016)
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showed that socioeconomic status is a stronger determinant of access to primary care and
quality and outcomes in those with T2DM than race and ethnicity; however, self-report of
DM and primary care experience without measuring health outcomes, use of secondary
data source, nonprobability sampling, and cross-sectional study design, and a
predominantly White study population will affect both internal and external validity of
study findings. Also results of a cross-sectional study by Bird et al. showed that
household income has a strong and independent association with the prevalence of T2DM
and some concordant comorbidities and physical inactivity; absence of African
Americans in the study population affects the generalizability of the results beyond the
study population. Research findings from studies carried out by Chow et al. (2016) and
Young et al. (2017) highlighted the importance and quality of health care access;
although the study by Young et al. was supposed to be a randomized control trial, not all
patients stuck to their assigned groups; also, the purposive sampling method utilized by
Chow et al. and lack of information about the racial or ethnic composition of the study
population will affect the generalization of the study results.
There are low eye care service utilization rates among adult African Americans
with DM, which result in lower screening rates among this population (Maclennan et al.,
2014; Yu et al., 2015). Research is scarce specifically on the associations between DM
comorbidities of hypertension and hyperlipidemia, gender, health care access diabetic
retinopathy among adult African Americans with diabetes in the United States. There was
a need to conduct research specifically on these factors that affect health care utilization
among adult African Americans with DM and diabetic retinopathy in the United States.
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Studies Related to the Research Questions
In this study, I analyzed the associations between gender, DM related comorbidity
of hypertension and hyperglycemia, and diabetic retinopathy among adult African
Americans in the United States. Studies reviewed on the association between gender and
diabetic retinopathy in adult African Americans are indeterminate, which warranted a
study to examine this relationship in this population (Research Question 1). Although the
literature review showed that concordant comorbidities of DM, hypertension, and
hyperlipidemia are risk factors for the development of diabetic retinopathy and its
progression to proliferative diabetic retinopathy, the study populations were
predominantly not African Americans (Atchison & Barkmeier, 2016; Chen et al., 2014;
Chew et al., 2014; Do et al., 2015; Lee et al., 2015; Lima et al 2016; Mendanha et al.,
2016; Romero-Aroca et al., 2016; Ting et al., 2016; Wat et al., 2016). The cross-sectional
design used for the studies on African Americans and purposive sampling can affect the
generalizability of the research findings (Papavasileiou et al., 2017; Penman et al., 2016).
There is a need for research on the association between DM comorbidities and diabetic
retinopathy among adult African Americans in the United States (research question 2).
Literatures reviewed showed that the achievement of metabolic control of
hyperglycemia, hypertension, and hyperlipidemia, early detection through regular eyescreening of patients with DM, and prompt management of diabetic retinopathy could
prevent the development of early diabetic retinopathy and the progression to the late
stages; these diabetes preventive services are dependent on health care utilization that
depend on health care access (Atchison & Barkmeier, 2016; Chen et al., 2014; Chew et
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al., 2014; Do et al., 2015; Lee et al., 2015; Lima et al., 2016; Mendanha et al., 2016;
Romero-Aroca et al., 2016; Ting et al., 2016; Wat et al., 2016). Three studies showed that
although African Americans are among those are disproportionately affected by diabetic
retinopathy, they had one of the lowest rates of diabetic retinopathy screening and
scheduled follow-up eye care utilization (Keenum et al., 2016; Maclennan et al., 2014;
Yu et al., 2015). There was a need to research the factors that affect health care access
among adult African Americans with DM (research question 3).
Definitions
Comorbidity: Is when there is concurrent existence of a disease and one or more
other diseases in an individual (Pantalone et al., 2015).
DM comorbidity: Can be concordant (similar) or discordant (not similar)
according to the management of DM (Magnan et al., 2015).
DM concordant comorbidities: DM, hypertension, hyperlipidemia, large and
small arterial diseases (Lin et al., 2015; Magnan et al., 2015; Mozaffarian et al., 2016;
Pantalone et al., 2015; Rosiek et al., 2016).
Diabetic Retinopathy: An extreme small blood vessel (arteriole) complication of
the eyes in both Type 1 and Type 2 diabetes; it is strongly related to both the duration of
poor blood sugar control in diabetes, and how controlled the blood sugar level is (ADA,
2018).
Health care access: The ability to gain entry into or utilize the health care service
(HealthyPeople.gov. (2018).
Albuminuria: Presence of albumin (type of protein) in the urine (ADA, 2018).
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African American: Individuals with any ancestry of African tribes, especially
those of Black African ancestors (Merriam-Webster, Incorporated, 2018).
Eye screening: Useful for those with DM in identification eye conditions such as
diabetic retinopathy that may result in vision loss (American Academy of
Ophthalmology, 2018a). An appropriate referral can then be made to an eye specialist for
further management (American Academy of Ophthalmology, 2018a).
Blood glucose: Principal sugar found in the body and the body’s primary source
of energy (ADA, 2018).
Diabetes mellitus (DM): A metabolic disorder characterized by chronic
hyperglycemia (continuing elevated levels of blood sugar) resulting from defects in
insulin action, insulin secretion, or both (WHO, 2018).
Type 1 Diabetes mellitus (T1DM) Medical problem with the body when blood
glucose level rises higher than normal because insulin is not being produced enough
(ADA, 2018).
Type 2 Diabetes mellitus (T2DM): Medical problem with the body when blood
glucose level rises higher than normal because insulin is not being appropriately used,
insulin not being produced enough (ADA, 2018).
Hemoglobin A1c (HBA1C): A biochemical measure of average blood sugar within
three months (WHO, 2018).
Macroangiopathy: Diseases of large arteries (WHO, 2018).
Microangiopathy: Diseases of small arteries called arterioles (WHO, 2018).
Neuropathy: Diseases of nerves (WHO, 2018).
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Nephropathy: Kidney disease (WHO, 2018).
Assumptions
NHANES 2011-2016 datasets were utilized in answering the proposed research
questions in this study. However, for the datasets’ appropriateness of secondary analysis,
it is assumed that they are adequate to answer the research questions (Mohajan, 2017;
Salimi & Ferguson‐Pell, 2017). It is therefore assumed that the datasets have an
appropriate sample, the random sampling method was utilized, and the quality of the
measurement instruments has been assured by the reliability and validity of
measurements that have been established in other settings (Anand et al., 2017; Salimi &
Ferguson‐Pell, 2017). The study sample of adult African Americans with DM represented
the population of interest in the study. Andersen model of health services use allowed for
the exploration of factors that affect health care access that is very significant in the
prevention of diabetic retinopathy among African Americans. As such it was suitable for
examining the association between independent variables of predisposing factor of
gender, the need factor of DM comorbidities, enabling factor of health care access, and
health care utilization measured as the dependent variable of diabetic retinopathy.
Scope and Delimitations
This was a cross-sectional study that explored the association between diabetes
comorbidities of hypertension and hyperlipidemia, gender, health care access, and
diabetic retinopathy in adult African Americans by secondary data analysis of 2011-2016
NHANES datasets. Adult African Americans with DM are disproportionately affected by
diabetic retinopathy, as such this population was suitable for this study. However, there

33
are delimitations of the study such as the exclusion of institutionalized individuals,
Americans resident outside the 50 states and the district of Colombia, and all active-duty
servicemen and women with their families residing overseas; as such the results of this
research may not be generalizable to those that did not qualify for inclusion in the survey
(CDC, 2017a). Also, a cross-sectional study examines relationships between multiple
variables in a specified population at a particular time-frame, so the results are fixed
without any indication of the order of events; cause and effect from simple association
cannot be established (Caruana, Roman, Hernández-Sánchez, & Solli, 2015; Mariani &
Pego-Fernandes, 2014; Omair, 2015; Setia, 2016).
Significance
Implications for positive social change from this study is that knowledge gained
from the study will be useful in planning and developing effective public health
interventions targeting specific African American populations, resulting in decreased
physical, mental, and socioeconomic burdens on this population. In this study,
determining the factors that influence health care utilization disparities among adult
African American populations with DM concordant comorbidities will help in identifying
barriers to the successful implementation of public health interventions in this population.
According to Walden University (2014), positive social change denotes
participation in activities that lead to an improvement in the lives of community
members, nationally or globally (Walden University, 2014). Understanding factors
responsible for DM comorbidity disparities and diabetic retinopathy in adult African
American populations can be utilized for their prevention and effective care through

34
development and implementation of culturally appropriate interventions (Sachdeva et al.,
2015). Social change implication of the research is that the results can be useful for the
successful planning and implementation of public health prevention programs for African
American populations. The consequence of which should be a decrease in the prevalence
DR and associated physical, mental, and socioeconomic burdens on populations,
especially the African American populations that are disproportionately affected (Lang,
& Marković, 2016; Lin et al., 2015). This should lead to less morbidity, disability, and
mortality from these diseases, which should lead to increased productivity that will lead
to an improvement of the socioeconomic status of individuals and the economic status of
the affected community.
Andersen model of health services use allowed for the exploration of factors that
affect health care access that is very significant in the prevention of diabetic retinopathy
among African Americans. The model’s constructs applied to this study should help in
understanding the predisposing, need, and enabling factors of health care utilization that
determine diabetic retinopathy among adult African Americans. In this study, a literature
review was conducted to identify studies on the influences of gender, DM comorbidities,
and health care access on diabetic retinopathy. The search yielded several articles, and
some of the articles related to this present study were selected. Major themes in the
selected articles are outlined below.
Summary
Andersen model of health services utilization allowed for the exploration of
factors that affect health care access that is very significant in the prevention of diabetic
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retinopathy among African Americans; it was suitable for examining the association
between independent variables of predisposing factor of gender, the need factor of DM
comorbidities, and enabling factor of health care access and health utilization that is
indirectly measured as the dependent variable of diabetic retinopathy (Andersen, 1968;
Andersen & Newman, 1973). Hypertension and hyperlipidemia have positive
associations with the development of diabetic retinopathy (Abdulghani, et al., 2018;
Beckman & Creager, 2016; Cheng et al., 2014; Do et al., 2015; Klimek et al., 2015; Lin,
Kent et al., 2015; Magnan et al., 2015; Mozaffarian et al., 2016; Pantalone et al., 2015;
Romero-Aroca et al., 2016; Rosiek et al., 2016; Solomon et al., 2017; Song et al., 2016;
Wat et al., 2016; Zhuo et al., 2014). Duration of diabetes, uncontrolled hyperglycemia
and hypertension are common important risk factors for the progression of diabetic
retinopathy to vision-threatening diabetic retinopathy or loss of vision (Chen et al., 2014;
Chew et al., 2014; Mendanha et al., 2016; Do et al., 2015; Lee et al., 2015; Lima et al.,
2016; Romero-Aroca et al., 2016; Ting et al., 2016; Wat et al., 2016). Longer duration of
diabetes, uncontrolled hyperglycemia, hypertension, and dyslipidemia are associated with
diabetic retinopathy in adult African Americans (Papavasileiou et al., 2017; Penman et
al., 2016). There are racial, ethnic, and socioeconomic disparities in health care access in
the United States (Bailey et al., 2016; Hu et al., 2016; Laiteerapong et al., 2015).
However, there is a dearth of public health research on the associations between a
predisposing factor of gender, need factors of DM comorbidities (hypertension and
hyperlipidemia), and enabling factor of health care access and utilization and diabetic
retinopathy among adult African Americans. This research examined the association

36
between these predisposing, need, enabling factors of health care utilization, and diabetic
retinopathy among adult African Americans. The results should fill a gap in public health
knowledge that should contribute to an improvement in population health planning and
implementation.
Conclusions
This research aimed at examining the association between predisposing, need and
enabling health care factors that influence health care utilization among African
Americans, which is responsible for diabetic retinopathy disparities in adult African
American populations. This should help in identifying barriers to the successful
implementation of public health interventions. A gap will be filled in literature with the
understanding of the factors responsible for diabetic retinopathy disparities in African
American populations.
In the next section, there is discussion about the research study design and data
collection that include research study design and the rationale for choosing the design;
methodology with its sub-sections of study population including its size, sampling and
sampling procedures used in data collection, study instrumentation, and study variables
operationalization; threats to validity; ethical considerations; and summary.
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Section 2: Research Design and Data Collection
Introduction
In this quantitative research, I examined associations between gender, DM
comorbidities, health care access (independent variables), and diabetes retinopathy
(dependent variable), among sampled adult African Americans in the United States.
Covariates were age groups, UACR, HBA1C level, marital status, adult education level,
and household income. I analyzed data from nationally representative datasets from the
NHANES 2011-2012, 2013-2014, and 2015-2016 cycles (see NCHS, n.d.) on DEMO
(demographics), DIQ (diabetes questionnaire), BPQ (blood pressure and cholesterol
questionnaire), ALB_CR (urine levels), HIQ (health insurance questionnaire), BPX
(blood pressure measurements), HDL, TCHOL, TRIGLY (blood levels), and GHB
(HBAIC level). Individual datasets for each cycle were merged to produce a final cycle’s
dataset, datasets from the three NHANES cycles were appended to produce the final
dataset, and new a data set specific to the study sample was created. Participants were
adult African Americans, aged 20 years and above, with a self-reported diagnosis of
diabetes (NCHS, n.d; Li et al., 2010; Yan et al., 2018). In this section, I discuss the
research study design and data collection. The discussions are in order of research study
design and the rationale for choosing the design; methodology with its subsections of
study population including its size, sampling and sampling procedures utilized used in
data collection, study instrumentation, and study variables operationalization; threats to
validity; ethical considerations; and summary.
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Research Design and Rationale
The design for this research was a quantitative cross-sectional study. The research
was approached through a retrospective analysis of nationally representative secondary
datasets, with both the independent and dependent variables extracted from NHANES
2011 – 2016 datasets. The independent variables and covariates represent constructs of
the Andersen model of health services utilization such as predisposing factors (age,
gender, marital status, education level, and household income); need factors of
comorbidities (DM, hypertension, hyperlipidemia, HBA1C and UACR); and enabling
factors of health care access (household income, level, current health insurance,
availability of regular diabetes doctor, diabetes specialists, and eye-screening service);
and the dependent variable of diabetic retinopathy that is a proxy measure of health
services utilization.
Quantitative research is used in quantifying relationships between the independent
or predictor variable(s) and the dependent or outcome variable(s) by way of experiments
or data analysis (Creswell, 2014). Researchers conduct cross-sectional studies to examine
relationships between multiple variables in a specified population (a representative
sample from the population) at a particular timeframe (Caruana et al., 2015; Mariani &
Pego-Fernandes, 2014; Omair, 2015; Setia, 2016). A correlational research design is used
to examine the existence of a significant linear relationship between the independent
(predictor) and dependent (outcome) variables; the direction and strength of that
relationship are also determined (Curtis et al., 2016; Omair, 2015). Correlational research
designs can be explanatory or predictive (Curtis et al., 2016; Omair, 2015). An
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explanatory correlational research design involves a cross-sectional data collection
approach, whereas for a predictive correlational research design, longitudinal data are
collected (Curtis et al., 2016; Omair, 2015). For this study, I used a correlational crosssectional design in examining whether there were significant associations between some
specific health care utilization factors and diabetic retinopathy among African
Americans. I chose the correlational cross-sectional study design considering the time
available for this dissertation, which would not have permitted a longitudinal study
design because of repeated observations that might be required over a long period
(Caruana et al., 2015; Curtis et al., 2016; Omair, 2016). Moreover, secondary data used
for this study were collected within specific time-periods (see NCHS, n.d.).
Cross-sectional studies are comparatively cheap and quick to carry out; multiple
measurements can be taken at the same time and is exclusive of variable(s) manipulation.
Although the results from cross-sectional studies are fixed without any indication of the
order of events and cause and effect from the simple association cannot be established,
the associations identified can then be studied rigorously by utilizing randomized control
trial (RCT) or cohort study (Mariani & Pego-Fernandes, 2014; Setia, 2016). For example,
identified associations and significant relationships between gender, DM comorbidities of
hypertension and hyperlipidemia, health care access, and diabetic retinopathy are
indicators of what can be studied further to ascertain cause and effect through RCT or
cohort study.
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Methodology
Population
The target population for the NHANES 2011-2012, 2013-2014, and 2015-2016
cycles was the noninstitutionalized civilian resident population of the United States
(Asiamah, Mensah, & Oteng-Abayie, 2017; NCHS, 2017a). The researchers used
oversampling to ascertain accurate representation of underrepresented groups that
included African Americans, adults Whites 60 years and over, Hispanics, and Asians
(NCHS, 2017). The target sample for this study were African Americans 20 years or over
with DM that were study participants in the 2011-2012, 2013-2014, and 2015-2016
NHANES cycles; a total of 634 (n = 634) study participants. The minimum sample size
of 308 for this research was calculated from an a priori power analysis utilizing
G*POWER 3.1.9.2 (Faul, Erdfelder, Buchner, & Lang, 2009).
Sampling in NHANES
Sampling is the procedure for selecting sampling units (individuals) from the
sample frame (Martinez-Mesa et al., 2016). It is important that the sampling plan is
specified early in the research process since the sample size estimation may be affected
by the method of sampling (Martinez-Mesa et al., 2016).
Sampling frame. The sample frame for research is a list of all individuals within
a target population that can be sampled based on the sampling procedure employed in the
study (Martinez-Mesa, Gonzalez-Chica, Duquia, Bonamigo, & Bastos, 2016). The
sampling frame for NHANES is all the U.S. counties (CDC, 2017a).
Sampling techniques. Quantitative researchers can use either probability
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sampling methods that employ random participants selection or nonprobability sampling
methods that utilize convenient and opportunistic sampling techniques for participant
selection (Martinez-Mesa et al., 2016; Omair, 2014). Probability sampling includes
simple random sampling, systematic random sampling, cluster sampling, multistage
sampling, and stratified random sampling (Martinez-Mesa et al., 2016; Omair, 2014).
Probability sampling techniques are preferred to nonprobability sampling techniques
because study results can be generalized beyond the study sample to the target population
(Martinez-Mesa et al., 2016; Omair, 2014). Complex multistage probability sampling
technique was utilized for 2011-2012, 2013-2014, and 2015-2016 NHANES cycles
(NCHS, n.d.). Multistage probability technique utilized involves (a) counties sampling
(primary sampling units); (b) segments sampling; (c) household sampling; and (d) person
sampling with the use of a computer algorithm that randomly selects some, all, or none of
the household members (CDC, 2018; Martinez-Mesa et al., 2016; Omair, 2014).
The combined datasets for 2011-2012, 2013-2014, and 2015-2016 NHANES
cycles was the sampling frame for this research. NHANES combined interviews
(household interview, questionnaires, and mobile examination center [MEC]
questionnaires), physical examination, and laboratory tests (CDC, 2017). After obtaining
written consent, trained personnel, including medical doctors, administer the
questionnaires and perform the medical examinations and laboratory tests (CDC, 2017
n.d.). In this research, I analyzed data on the target sample from the 2011-2012, 20132014, and 2015-2016 NHANES cycles.
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NHANES data describe the prevalence or trends of disease, nutrition, risk
behaviors, and environmental exposures in the US population (CDC, 2017). Probability
sampling allows the survey results to be generalizable to the larger population from
which the study sample was drawn (CDC, 2017a; NCHS, n.d.). NHANES, which was
conducted on a periodic basis from 1970 but turned to a continuous survey in 1999, is a
cross-sectional population-based survey that collects data on demographics, diet and
nutritional status, risk factors, adolescent health, environmental exposure, reproductive
health, and chronic diseases on a nationally representative sample of the U.S. population
(NCHS, 2017). Although 43,090 individuals were selected for NHANES 2011-2012,
2013-2014, and 2015-2016 cycles from 30 different counties in each cycle, the interview
was completed by 29,902 individuals, and 28,695 persons went through physical
examination; response rate for the interviewed sample was 69%; and 66.6% for the
examined sample (NCHS, n.d.).
Data Collection and Utilization Procedures for the Current Study
I analyzed data from the combined 2011-2012, 2013-2014, and 2015-2016
NHANES datasets, such as DEMO.XPT (demographics), DIQ.XPT (diabetes
questionnaire), BPQ.XPT (blood pressure and cholesterol questionnaire), ALB_CR.XPT
(urine levels), HIQ.XPT (health insurance questionnaire), BPX.XPT (blood pressure
measurements), HDL.XPT, TCHOL.XPT, TRIGLY.XPT and GHB.XPT (blood levels)
were analyzed (NCHS 2013; NCHS, 2015; NCHS, 2017b). NHANES data have been
utilized as secondary data sources for some descriptive and analytical research that
include behavioral and chronic disease-related studies such as diabetes retinopathy
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(Ahluwalia et al., 2017; Shah, 2016; Song et al., 2016; Zhang et al., 2010). The 20152016 NHANES cycle dataset that was previously downloaded for the study did not yield
sufficient study sample to meet the minimum study sample requirement of 308 obtained
from a priori power analysis, this necessitated the acquisition of additional datasets from
2011-2012 and 2013-2014 NHANES cycles. NHANES datasets are in the public domain
like other data and materials created by federal agencies, which may be reproduced; there
was no requirement for special permission for gaining access to them (CDC, 2017a).
Study Sample Size: Power Analysis
Performing sample size determination by power analysis requires effect size,
desired Type I error rate (α) that is often set at p < .05, and the power, that is based on the
desired Type II error rate, which is also conventionally set at 80% (Columb & Atkinson,
2016; Faul et al., 2009). In using power analysis to determine the sample size for multiple
regression analysis of the dataset for this research, the G*Power application was used
(Faul et al., 2009). I selected z test as test family and logistic regression as the statistical
test were selected. Power was set to .80, the desired Type I error rate (α) was set to .05;
odds ratio at 1.5, and 2-tail hypothesis direction were selected based on the nondirectional hypothesis for this research. The minimum sample size of 308 for this
research was calculated from an a priori power analysis utilizing G*POWER (Faul et al.,
2009).
Instrument and Operationalization of Variables
Data for 2011-2012, 2013-2014, and 2015-2016 NHANES cycles were from
initial home interviews and health examination section of the study conducted in the
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mobile examination center (NCHS, n.d.). Specific items and scales utilized from the
combined 2011-2012, 2013-2014, and 2015-2016 NHANES datasets included
DEMO.XPT (demographics), DIQ.XPT (diabetes questionnaire), BPQ.XPT (blood
pressure and cholesterol questionnaire), ALB_CR.XPT (urine levels), HIQ.XPT (health
insurance questionnaire), BPX.XPT (blood pressure measurements), HDL.XPT,
TCHOL.XPT, TRIGLY.XPT and GHB.XPT (blood levels) were analyzed (NCHS 2013;
NCHS, 2015; NCHS, 2017b). I did not need any permission to use these datasets. The
different datasets from particular NHANES cycle were merged, the final datasets from
the three NHANES cycles were appended, and new data set peculiar to the study sample
was created.
To answer the research questions, there was a need to recode some of the
variables that have been used by NHCS in the original data collection to new variables
and merging of variables to form composite variables such as DM comorbidity and health
care access. The new dataset contains some demographic variables such as age groups,
marital status, gender, annual household income, and adult education level; health
insurance coverage; diabetes affected eyes/had retinopathy; high blood pressure and high
cholesterol; UACR and HBAIC level. The variables were arranged into diabetic
retinopathy (dependent variable); DM comorbidities, gender, health care access
(independent variables); and age groups, HBA1C level, UACR, marital status, household
income, and education level (covariates). A complex sample plan for complex sample
analysis was created. The complex sampling plan was developed to assure correct data
weighting, considering the effect of oversampling of African Americans and some other
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groups that would have resulted in samples that were no longer representative of the
populations, with consequential inaccurate findings. The final dataset was stored.
Diabetic retinopathy, the dependent variable utilized for this study was assessed
by participants’ self-report of having been informed by a doctor that the eyes were
affected by diabetes; the level of measurement is binomial categorical. Assessment of
DM comorbidities of hypertension and hyperlipidemia were through participants selfreport of being informed of by a health professional about having high blood pressure
more than twice, an average systolic blood pressure at the medical examination center
(MEC) of ≥130mmhg, and self-report of current use of medications for high cholesterol
and low blood HDL level at the MEC; level of measurement is binomial categorical
(American Heart Association (2019; U.S. National Library of Medicine [NIH], 2018).
Gender is assessed through a self-report of being female or male; binomial categorical.
Health care access was assessed by combining covered by health insurance, seeing a
regular doctor for diabetes, last time had pupils dilated for exams variables into one
variable with a binomial categorical level of measurement.
Covariate of age groups was assessed by self-report of age in years at screening,
the age groups are as advised by NCHS; it is an ordinal categorical variable (NCHS,
2018). HBA1C level was assessed by the participants HBA1C level, a continuous level of
measurement (ADA, 2018; Garber et al., 2018). Assessment of participants’ UACR was
by the participants’ UACR levels, a continuous level of measurement (ADA, 2018).
Marital status is a binomial categorical variable. Annual household income and education
level variables are ordinal categorical. For complex sample analysis, variables that
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identified the sample strata, sample clusters, and sample weight are included. The
following table shows the operationalization of study dependent and main independent
variables, covariates, and complex sample parameters
Table 1
Operationalization of Study Independent, Dependent, and Covariate Variables
Variables

Survey questions

Data code

Variable type

Diabetes retinopathy

Diabetes affected
eyes/had retinopathy?

0 = No. 1 = Yes

Binomial dependent

DM comorbidities

1. Ever told you had
high blood pressure 2+
times
2. Systolic hypertension
3. Now taking meds for
high cholesterol
4. Low HDL

0 = No DM comorbidity
1 = DM comorbidity

Binomial independent

Age groups

Age in 20-39; 40-59;
and 60 years and over

1 = 20-39 years
2 = 40-59 years
3 = 60 years and over

Ordinal covariate

Gender

Gender

Health care access

1. Covered by health
insurance
2. Has a regular doctor
for diabetes
3. Last time had pupils
dilated for exam?

0 = male
1 = female

Binomial independent

0 Did not have health
care access
1 Had health care access

Binomial independent

0.21 to 9000

Continuous covariate

3.5 to 17.5

Continuous covariate

1 = Less than high
school
2 = High school Grad/
GED or Equivalent

Ordinal covariate

UACR
Urine
Albumin/creatinine ratio
(mg/g)
HBAIC
Blood HBAIC level %
Adult education level
Adult Education level

(table continues)
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Variables

Survey questions

Data code

Variable type

3 = Some College or
AA degree

Marital status

Annual household
Income

Marital status

Annual household
income

4 = College graduate
or above
1 Married
2 Divorced, widowed,
and separated
3 Never married and
living with a partner
0 = Refused, Don’t
know, Missing
1 = less than $20,000
2 = $20,000-$44,999
3 = $45,000-$74,999
4 = $75,000-$99,999
5 = $100,000 & over

Categorical covariate

Ordinal covariate

Masked variance pseudostratum

SDMVSTRA

n/a

Complex sampling
weighting variable

Masked variance pseudoPSU

SDMVPSU

n/a

Complex sampling
weighting variable

Full sample 2-year MEC
exam weight

WTMEC2YR

n/a

Complex sampling
weighting variable

Data Analysis
Data analysis was conducted with SPSS (Version 25). I downloaded datasets from
2011-2012, 2013-2014, and 2015-2016 NHANES cycles, such as DEMO.XPT
(demographics), DIQ.XPT (diabetes questionnaire), BPQ.XPT (blood pressure and
cholesterol questionnaire), ALB_CR.XPT (urine levels), HIQ.XPT (health insurance
questionnaire), BPX.XPT (blood pressure measurements), HDL.XPT, TCHOL.XPT,
TRIGLY.XPT and GHB.XPT (blood levels) (NCHS 2013; NCHS, 2015; NCHS, 2017b).
To answer the research questions, some variables previously used by NCHS in the
original data collection were transformed into new variables, including composite
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variables. Final variables for this study are mostly categorical with two continuous
variables (HBAIC and UACR). Individual files from each NHANES cycle were merged
into datasets for the respective cycles that were then appended to form a final dataset for
2011-2012, 2013-2014, and 2015-2016 NHANES cycles. A new dataset peculiar to the
study sample of African Americans, 20 years and over, with a self-reported diagnosis of
DM was subsequently created. The final dataset was then prepared for analysis.
A complex sampling plan was developed to assure correct data weighting that
should lead to accurate findings, considering the effect of oversampling of African
Americans and some other groups that would have resulted in samples that were no
longer representative of the populations with consequential inaccurate findings (NCHS,
2018). Missing values were managed by listwise default deletion function of SPSS that
automatically drops a missing case from analysis instead of its deletion from the dataset;
it is automatically applied with logistic regression analysis in SPSS irrespective of any
previous data cleaning method (IBM, 2016). In preventing the introduction of bias to
estimates such as mean values with resultant misestimated values, handling outliers is
important prior to data set analysis (Kwak & Kim, 2017). Identified outliers by an outlier
detection function in binary logistics for glycohemoglobin and urine albumin-creatinine
ratios were less than 5% of values of the two variables (Kwak & Kim, 2017; Sindhumol,
Gallo, & Scrinivasan, 2017). High collinearity presence in a multiple linear or logistic
regression model may result from predictors’ high variances leading to inaccurate
estimations, which can evoke doubts about the results of the analysis (Salmerón, García,
& García, 2018). As such, collinearity detection by a variance inflation factor (VIF) and
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tolerance is a necessary initial step compulsory first step in every multiple regression
analysis (Salmerón et al., 2018). A variance inflation factor value of less than 10 or
tolerance value greater than 0.1 is accepted as the absence of collinearity in a multiple
regression model (Salmerón et al., 2018). Absence of extreme collinearity within the
independent variables for this study was asserted with variance inflation factor values of
less than 10 (see Table 7).
I conducted preliminary descriptive statistics. Frequencies and percentages were
calculated for the categorical variables, and minimum and maximum scores, means, and
standard deviations were computed for the two continuous variables (see Table 2)
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Table 2
Descriptive Analysis Plan for Dependent and Independent Variables, and Covariates
Variables

Variable type

Descriptive analysis

Diabetes retinopathy

Binomial Dependent

Percentages or
Proportions

Ordinal Covariate

Means and standard
deviations

Age

groups

DM Comorbidities

Binomial Independent

Gender

Binomial Independent

Percentages or
Proportions

Health Care Access

Binomial Independent

Percentages or
Proportions

Adult Education Level

Ordinal Covariate

Percentages or
Proportions

Marital Status

Categorical variable

Percentages or
Proportions

Annual Household

Ordinal Covariate

Percentages or
Proportions

Continuous Covariate

Minimum, Maximum,
Means and Standard
deviations

Continuous Covariate

Minimum, Maximum,
Means, and Standard
deviations

Percentages or
Proportions

Income
UACR level

HBAIC level
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Research Questions and Hypothesis
The following research questions and hypothesis were addressed in this study:
RQ1: Is there an association between gender and diabetes retinopathy among
adult African Americans in the United States?
Hо1: There is no association between gender and diabetes retinopathy among
adult African Americans in the United States
H₁1: There is an association between gender and diabetes retinopathy among
adult African Americans in the United States.
RQ2: Is there an association between DM-related comorbidities of hypertension,
hyperlipidemia, and diabetic retinopathy among adult African American populations in
the United States?
Hо2: There is no association between DM-related comorbidities of hypertension,
hyperlipidemia, and diabetic retinopathy among adult African American populations in
the United States.
H₁2: There is an association between DM-related comorbidities of hypertension,
hyperlipidemia, and diabetic retinopathy among adult African American populations in
the United States.
RQ3: Is there an association between health care access and diabetic retinopathy
among adult African Americans in the United States?
Hо3: There is no association between health care access and diabetic retinopathy
among adult African Americans with DM in the United States.
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H₁3: There is an association between health care access and diabetic retinopathy
among adult African Americans with DM in the United States.
Level of significance (α) = 0.05.
Statistical Tests and Interpretation of Results
Sample characteristics were described with descriptive statistics. Percentages or
proportions are for the categorical independent and dependent variables, and minimum
and maximum scores, means, and standard deviations were computed for the continuous
variables. The dependent variable (diabetic retinopathy) in this study is dichotomous, as
such the relationships between diabetic retinopathy and the independent variables for this
study can be examined by logistic regression (Ranganathan, Pramesh, &Aggarwal, 2017).
Three logistic regressions were conducted to examine (a) the association between gender
and diabetic retinopathy among adult African Americans in the United States; covariates
include age groups, HBA1C level, UACR, marital status, adult education level, and
annual household income; (b) the association between DM comorbidities of hypertension
and hyperlipidemia and diabetic retinopathy among adult African American populations
in the United States; covariates are age groups, HBA1C level, UACR, marital status,
adult education level, and annual household income; and (c) association between health
care access and diabetic retinopathy among adult African-Americans in the United States;
covariates are age groups, HBA1C level, UACR, marital status, adult education level, and
annual household income. These chosen covariates have been reported as risk factors for
diabetic retinopathy in various studies on risk factors for diabetic retinopathy in various
ethnic/racial populations, including adult African-American populations.
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For statistical analysis, the independent variables and the covariates were included
in all models; the results might have shown any significant relationship between gender
and diabetic retinopathy in model 1, between DM comorbidities of hypertension and
hyperlipidemia and diabetic retinopathy in model 2, and between health care access and
diabetic retinopathy in model 3, after controlling for HBAIC level, age group, UACR,
marital status, adult education level, and annual household income. Results of logistic
regression analysis were interpreted as odds ratios, the associated confidence intervals,
and p-values (Sperandei, 2014). Interpretation formats for both dependent and
independent variables are shown in Table 3.
Table 3
Plan for statistical analysis
Variables

Statistical analysis method

Interpretation of results

Model 1

Multiple logistic regression
analysis

Odds ratios, the associated
confidence intervals, and
p values

Model 2

Multiple logistic regression
analysis

Odds ratios, the associated
confidence intervals, and
p values

Model 3

Multiple logistic regression
analysis

Odds ratio, the associated
confidence intervals, and
p values

There are assumptions to be met to ensure the accuracy of statistical findings of
logistic regression analysis; these assumptions are different from those of multiple linear
regression analysis in some areas (McDonald, 2014; Sperandei, 2014). For example,
linear relationship between the dependent and independent variables is not required,
residuals are not required to be normally distributed, and there is no requirement for
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homoscedasticity (McDonald, 2014; Sperandei, 2014). However, assumptions associated
with logistic regression include correct specification of the logistic regression model,
specified absence of multicollinearity absence, inclusion of all relevant predictors, and
large sample size (McDonald, 2014; Pituch & Stevens, 2016; Sperandei, 2014).
From the omnibus test of model coefficients table and the Nagelkerke R2 from the
model summary table, the overall model was significant (Pituch & Stevens, 2016) The
individual predictors are relevant based on p values of .000 (< 0.05), the Wald test, and
the EXP(B) (odds ratio) (Pituch & Stevens, 2016). Absence of collinearity within the
independent variables for this study was determined with VIF values of less than 10 (see
Table 7). According to Long (1997), for logistic regression, sample size larger than 500 is
sufficient (Long, 1997). The sample size for this study (634) is adequate (see Long,
1997).
Threats to Validity
The main aim of NHANES is the production of a wide range of health and
nutrition statistics based on age, gender, and race composition of the United States
population (NCHS, 2017). All secondary data that include NHANES data requires a
thorough assessment of not only the results but also rigors of the studies by assessment of
data collection methods through measurement of validity and reliability measurement of
instruments (Mohajan, 2017). Validity is the extent to which a concept is accurately
measured in a quantitative study (Mohajan, 2017; Salimi & Ferguson‐Pell, 2017). Types
of validity include internal validity that refers to whether the observed effects on the
dependent variable are related to the independent variables and not due to confounding
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variables; external validity, which is the extent the results can be generated beyond the
study population; and construct validity that refers to how well the research instrument
measures the constructs being studied (Mohajan, 2017; Salimi & Ferguson‐Pell, 2017).
Threats to external validity affect the generalization of the study results beyond
the study population, which in the NHANES, may be significant because of the
oversampling of specific subgroups such as the African-Americans that could have
resulted in response rate bias, the study result may not be representative of the general
population (Meterko et al., 2017). The large sample used for the NHANES could have
reduced the generalizability threat of the study results. Threats to internal validity include
research factors, which have not been accounted for the effect on the outcome variables
such as confound bias and reverse causation in correlational studies; self-reporting that
can lead to recall bias due to inaccurate or incomplete recollections of past events or
experiences, and reporting bias, which could arise from study participants prior
knowledge of participation and the process involved, leading to suppression of
information that may be deemed not to be socially acceptable (Salimi & Ferguson-Pell,
2017). Internal validity was minimized in 2011-2012, 2013-2014, and 2015-2016
NHANES cycles with the multistage probability sampling technique that was used.
Confounding occurs when the observed effect on the dependent variable is related to the
independent variable(s) and another factor that is independently associated with both
dependent and independent variables, this can be corrected by covariate analysis (Salimi
& Ferguson-Pell, 2017). The threat to construct validity may be due to the poor
operationalization of study constructs, which for NHANES may be minimal because of
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previous repeated use of the measurement instruments (Pierannunzi, Hu, & Balluz, 2013;
Salimi & Ferguson-Pell, 2017). In a cross-sectional study, reverse causation is due to the
inability to define the temporal precedence of variables (Salimi & Ferguson-Pell, 2017).
Ethical Procedures
This study utilized secondary data using de-identified data from 2011-2012, 20132014, and 2015-2016 cycles datasets such as DEMO.XPT, DIQ.XPT, BPQ.XPT,
HIQ.XPT, BPX.XPT, HDL.XPT, TCHOL.XPT, TRIGLY.XPT and GHB.XPT (NCHS
2013; NCHS, 2015; NCHS, 2017b).
I did not need any permission to use these datasets, and I did not need to obtain
permission from NCHS before acquiring the dataset. The datasets were acquired upon
obtaining the required Walden University Institutional Board (IRB) approvals before
accessing the datasets for analysis. The IRB approval number is 03-26-19-0397499
Ethical guidelines for the protection of human subjects that must have been
followed by NCHS included: the approval of the original request for new protocol #201117 by the NCHS review board; review process was utilized by NHANES; data collection
was protected by public law (45 CFR 46); and participant consent was approved and
documented by the NCHS review board before the commencement of the study (NCHS,
2017f; Office for Human Research Protections. 2016). Verbal consent was provided by
the primary study participants for 2011-2012, 2013-2014, and 2015-2016 NHANES
during the process of recruitment, and data were subsequently anonymized (NCHS, n.d).
2011-2012, 2013-2014, and 2015-2016 NHANES datasets do not contain any
identification of study participants. Upon obtaining IRB approval from Walden
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University, the four datasets will be downloaded from the NCHS site and saved in a
separate jump drive secured in my workbag and will only be accessed as needed for my
doctoral study alone. The datasets and all related files will be kept in my home safe and
destroyed later.
Summary
In this chapter, I provided a detailed discussion of the research design and data
collection for my study on the association between gender, DM comorbidity, health care
access, and diabetic retinopathy among adult African Americans. The chapter
commenced with a discussion of the study research design and the rationale for its use,
followed by an exhaustive discussion on methodology including study population and its
size determined by a priori power analysis utilizing G*Power; sampling and sampling
procedures utilized used in data collection for the 2011-2012, 2013-2014, and 2015-2016
NHANES cycles, and the current research; study instrumentation and study variables
operationalization; data analysis plan; threats to validity with particular reference to
internal, external, and construct validity; and ethical considerations. In the next section, I
will discuss the presentation of results and findings.
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Section 3: Presentation of the Results and Findings
Introduction
This research is aimed at examining associations between health utilization
factors of gender, DM comorbidities of hypertension and cholesterol, and health care
access, and diabetic retinopathy among adult African Americans. In this section, after
describing the data collection method for the 2011-2012, 2013-2014, and 2015-2016
NHANES cycles data, I present the results and findings from data analysis using SPSS
(Version 25). Discourse on results encompasses descriptive statistics on study
participants, evaluation of statistical assumptions as appropriate to the study, report on
statistical analysis findings organized by research questions and hypotheses, and report
on results of posthoc analyses of statistical tests, as applicable.
Data Collection Method of 2011-2016 NHANES Data
For this study, I used data from a nationally representative combined dataset of
2011-2012, 2013-2014, and 2015-2016 NHANES cycles. NHANES uses complex,
multistage probability design with a large sample to assure reliability and precision of the
health status of the target population and selected sample (CDC/NCHS, 2017a). Upon
obtaining IRB approvals, I downloaded individual datasets for each of the three cycles
(see NCHS 2013; NCHS, 2015; NCHS, 2017b ) such as DEMO.XPT (demographics),
DIQ.XPT (diabetes questionnaire), BPQ.XPT (blood pressure and cholesterol
questionnaire), ALB_CR.XPT (urine levels), HIQ.XPT (health insurance questionnaire),
BPX.XPT (blood pressure measurements), HDL.XPT, TCHOL.XPT, TRIGLY.XPT and
GHB.XPT (blood levels). Acquiring the three combined datasets was necessary to obtain
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a large sample of 500 or more participants for logistics regression analysis for this study
(see Long, 1997).
I merged the individual datasets for each respective year by participant sequence
number and subset to include only observations pertinent to this research to form a
dataset for the year. The resulting three datasets were appended to create a combined
dataset that I sorted based on variables of the African American race, age 20 years and
over, and DM. The number of sampled individuals for the 2011-2012, 2013-2014, and
2015-2016 NHANES cycles was 43,090; of these participants, 29,902 (69%) had been
interviewed, and 28,695 (66.6%) had been examined (NCHS, 2013, 2015, 2017). There
were 7121 (18.2%) African Americans interviewed, 3809 (52.8%) of whom were 20
years of age or older, and 634 (8.9%) of whom were 20 years of age or older with selfreport of diabetes diagnosis (NCHS, 2013, 2015, 2017).
To answer the research questions, I transformed some of the variables that have
been used by NHCS in the original data collection into new variables, including
composite variables (diabetes comorbidity and health care access). Final variables for this
study were predominantly categorical, except for two continuous variables (HBA1C
levels and UACR). A complex sampling plan was developed to assure correct data
weighting that should lead to accurate findings, considering the effect of oversampling of
African-Americans and some other groups that would have resulted in samples that were
no longer representative of the populations, with consequential inaccurate findings and
poor generalizability (see NCHS, 2018).
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Using SPSS (Version 25), I performed descriptive and inferential data analysis of
the final dataset utilizing the created complex sample plan developed to assure correct
data weighting and national representativeness of the findings.
Independent categorical variables are automatically dummy coded by SPSS in
logistic regression, with 0 as a reference factor. I obtained weighted and unweighted
frequencies and percentages for the categorical independent variables and the dependent
variables, as well as mean, standard deviation, minimum, and maximum scores for the
continuous variables of HBAIC and UACR.
Results
Descriptive Statistics of Demographic and Baseline Study Variables
The final dataset consisted of 634 African Americans age 20 years or older with
self-report of diabetes (n = 634); average age was 58.96 years (SD = 12.875). Males were
52.7% of the study sample, and married participants were 40%. The proportion of study
sample in the age group 60 years and over was 62.1%. Over half of the study sample
(63.2%) reported annual household income of less than $50,000, and the proportion of
study participants with at least some college education or higher was 66.4%. Table 4
illustrates dependent and independent variables for this study, with unweighted and
weighted frequencies and percentages for the variables.
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Table 4
Unweighted and Weighted Frequencies and Percentages for the Dependent and
Categorical Independent Variables for the Study
Characteristic

Unweighted
frequencies

Unweighted
percentage

Weighted
frequencies

Weighted
percentage

Diabetic retinopathy
No
Yes

498
136

78.5
21.4

8502144.436
2110093.204

80.1
19.9

391
243

61.7
38.3

6454005
4158233

60.8
39.2

Gender
Male
Female

334
300

52.7
47.3

4805837
5806400

45.3
54.7

Health care access
No
Yes

603
31

61
38

6454005
4158233

60.8
39.2

20-39 years

23

564420

5.3

40-49 years
60 years and over

217
394

3.6
34.2
62.1

4864844
5182974

45.8
48.8

177
162
118
38
57

30.1
27.5
20.0
6.5
9.7

2895258
2716332
1964410
632913
1121392

29.2
27.4
19.8
6.4
11.3

260
240

41.0
37.9

4122288
4079050

38.8
38.4

33

21.0

2398910

22.6

Diabetes comorbidity
No
Yes

Age groups

Annual household
income
Less than $20,000
$20,000 to $44999
$45,000 to $74,999
$75,000 to $99,999
$100,000 and over
Marital status
Married
Widow, divorced
Separated
Never married
Living with a partner
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Descriptive statistics for continuous pertinent baseline and independent variables
are shown in Table 5. The average HBAIC level was 7.5% (SD = 2.11) and UACR was
232.00 mg/g (SD = 687.14). Average systolic blood pressure was 134 mmhg (SD =
20.67) and diastolic blood pressure was 69 mmhg (SD= 16.44). Average total cholesterol
was 181.46 mg/dl (SD = 48.72), HDL cholesterol was 51.3 mg/dl (SD =15.49), and LDL
was 102.64 mg/dl (SD = 39.04).
Table 5
Descriptive Statistics for Continuous Pertinent Baseline and Independent Study
Variables
Minimum

Maximum

M

SD

HBA1C (%)

4.60

17.80

7.52

2.11

UACR (mg/g)

1.91

5928.00

232.00

687.14

Systolic blood pressure (mmHg)

86

190

134

20.667

Diastolic blood pressure (mmHg)

0

110

69.80

16.493

Total cholesterol (mg/dl)

75

389

181.46

48.723

Direct HDL-Cholesterol (mg/dl)

22

156

51.43

15.489

LDL-Cholesterol (mg/dl)

15

240

102.64

39.040

Table 6 depicts the unweighted and weighted frequencies and percentages for the
composite independent categorical variables’ factors. For example, for health care access,
89.6% of study participants reported having health insurance coverage, 80.0% reported
having a regular diabetes doctor, and 76.8% reported having had recommended dilated
eye examination. For diabetic comorbidities, about 68.5% reported being informed that
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they had high blood pressure twice and 35.7% had systolic high blood pressure recorded;
current use of cholesterol medications was reported in about 55.25%, and 18.5% had low
HDL blood measurement.
Table 6
Descriptive Statistics for Composite Independent Categorical Variables’ Factors
Factor

Unweighted
frequencies

Unweighted
percentage

Weighted
frequencies

Weighted
percentage

Covered by health
insurance
No
Yes

65
568

10.3
89.6

1304773
9294088

12.3
87.6

Regular diabetes doctor
No
Yes

127
507

20.0
80.0

2176647
8435590

20.5
79.5

Last dilated eye exam
Not as recommended
As recommended

139
495

21.9
78.1

2463269
8148969

23.2
76.8

Told had high blood
pressure twice
No
Yes

59
438

9.2
68.5

976194
7271466

9.2
68.5

Systolic high blood
pressure
No
Yes

425
209

64.3
35.7

6824038
3788200

64.3
35.7

44
350

6.9
55.2

788858
5790169

7.4
54.6

325
74

81.5
18.5

5297295
1161142

82.0
18.0

Now taking cholesterol
meds
No
Yes
Low HDL
No
Yes
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Inferential Statistics
Three research questions and hypothesis were addressed in this study. The
dependent variable of diabetic retinopathy was a binary response variable. Complex
samples logistic regression was conducted due to the absence of complex samples binary
logistic regression option in SPSS. Assumptions associated with logistic regression such
as the correct specification of the logistic regression model, the inclusion of all relevant
predictors, large sample size, and absence of multicollinearity were met (McDonald,
2014; Pituch & Stevens, 2016; Sperandei, 2014). Absence of multicollinearity was
assured with the variance inflation factor (VIF) values of the independent variables that
were less than 10, as shown in Table 7.
Table 7
Variance Inflation Factor Values for Independent Variables and Covariates
Variables

VIF*

Urine albumin-creatinine ratio

1.067

Marital status

1.246

Age groups

1.248

Annual household income

1.439

Diabetes comorbidity

1.046

Health care access

1.551

Adult education level

1.164

Gender

1.128

HBAIC

1.128

*Note: Multicollinearity is absent with VIF value of < 10 (Pituch & Stevens, 2016; Salmerón et al., 2018).
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I conducted a two-step complex samples logistic regression analysis to answer
each research question (see Sperandei, 2014). The first step was a model to investigate
the relationship between the main predictor variable and the dependent variable of
diabetic retinopathy; it served as a comparison model (Sperandei, 2014). The second step
was a full model to determine the strength of the effect of multiple independent variables
(main independent variables and covariates) on the dependent variable (see Sperandei,
2014).
Research Question 1
Is there an association between gender and diabetes retinopathy among adult
African Americans in the United States?
Hо1: There is no association between gender and diabetes retinopathy among
adult African Americans in the United States.
H₁1: There is an association between gender and diabetes retinopathy among adult
African Americans in the United States.
α = .05
To address this question, a two-step complex samples logistic regression analysis
was conducted (see Sperandei, 2014). The first step of the regression analysis was a
reduced model with the predictor variable of gender and the dependent variable of
diabetic retinopathy. From the default predicted versus observed classification table in
SPSS, this regression model correctly classified participants 80.1% of the time. The
overall model for this step was not significant, x² (1) = 3.795, p = .063, Nagelkerke R² =
.006. The null hypothesis that there was no association between gender and diabetes
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retinopathy among adult African American populations in the United States was not
rejected. This model functioned as the model for comparison.
The second step of logistic regression analysis was full a full model with the
predictor variable of gender, the dependent variable of diabetic retinopathy, and all
covariates of age groups, HBA1C level, UACR, marital status, education level, and
annual household income. This model correctly classified participants 81.2% of the time;
a statistically significant improvement over the comparison model was provided, x² (7) =
134.113, p < .001, Nagelkerke R² = .141. UACR, annual household income, and adult
education level were statistically significant. The null hypothesis that there was no
association between the combined predictor variables of gender and the covariates and
diabetic retinopathy among adult African American populations in the United States was
rejected.
However, gender, the main variable of interest was not significant in the two
models (p = .063 and .271); the null hypothesis for Research Question 2 was not rejected.
Table 8 displays the results of the comparison and full models for the logistic regression
for the association between gender and diabetic retinopathy in African Americans.
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Table 8
Complex Samples Logistic Regression for Association Between Gender and Diabetic Retinopathy

Step

Variable

1

Gender

2

Gender (ref: Male)
HBAIC
Urine Albumin-Creatinine Ratio
Marital Status (ref: Married)
Annual Household Income (ref:
Less than $20,000)
Age Groups (ref: 60-80 years
old)
Adult Education Level (ref: Less
than High school Education)

p

OR

95% CI for OR
Lower
Upper

3.80

.063

0.73

0.53

1.02

1.28

.271

0.76

0.45

1.27

0.01
107.34
0.25
17.31

.919
.000
.623
.000

1.00
1.03
0.90
1.15

0.93
1.01
0.65
1.07

1.07
1.04
1.30
1.24

3.51

.075

0.73

0.51

1.04

4.42

.048

0.86

0.74

1.00

Wald x²
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Research Question 2
Is there an association between DM-related comorbidities of hypertension,
hyperlipidemia, and diabetic retinopathy among adult African American populations in
the United States?
Hо2: There is no association between DM-related comorbidities of hypertension,
hyperlipidemia, and diabetic retinopathy among adult African American populations in
the United States.
H₁2: There is an association between DM-related comorbidities of hypertension,
hyperlipidemia, and diabetic retinopathy among adult African American populations in
the United States.
α = .05
To address this question, a two-step complex samples logistic regression analysis
was conducted (Sperandei, 2014). The first step of the regression model was a reduced
model with the predictor variable of DM comorbidities and the dependent variable of
diabetic retinopathy. From the default predicted versus observed classification table in
SPSS, this regression model correctly classified participants 80.1% of the time. The
overall model for this step was not significant, x² (1) = 1.505, p < .232, Nagelkerke R² =
.001. The null hypothesis that there was no association between DM comorbidities of
hypertension, hyperlipidemia, and diabetic retinopathy among adult African American
populations in the United States was not rejected. This model functioned as the model for
comparison.
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The second step of the logistic regression model was full a full model with the
predictor variable of DM comorbidities, the dependent variable of diabetic retinopathy,
and all covariates of age groups, HBA1C level, UACR, marital status, education level,
and annual household income. UACR and annual household income were statistically
significant. This model correctly classified participants 81.2% of the time; a statistically
significant improvement over the comparison model was provided, x² (7) = 131.769, p <
.001, Nagelkerke R² = .141. The null hypothesis that there was no association between
the combined predictor variables of DM comorbidity and covariates and diabetic
retinopathy among adult African American populations in the United States was rejected.
However, DM comorbidity, the main variable of interest was not significant (p =
.232 and .098); the null hypothesis for Research Question 1 was not rejected. Table 9
displays the results of the comparison and full models for the logistic regression for the
association between DM comorbidity and diabetic retinopathy in African Americans.
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Table 9
Complex Samples Logistic Regression for Association Between DM Comorbidity and Diabetic Retinopathy

Step

Variable

Wald x²

p

OR

95% CI for OR
Lower
Upper

1

Diabetic comorbidity

31.55

.232

1.30

0.95

1.78

2

Diabetic comorbidity (ref: No
comorbidity)
HBAIC
Urine Albumin-Creatinine Ratio
Marital Status (ref: Married)
Annual Household Income (ref:
Less than $20,000)
Age Groups (ref: 60-80 years
old)
Adult Education Level (ref: Less
than High school Education)

3.00

.098

1.30

0.95

1.78

0.02
108.54
0.12
12.38

.905
.000
.734
.002

1.00
1.02
0.99
1.13

0.93
1.00
0.67
1.05

1.06
1.04
1.32
1.23

3.47

.077

0.73

0.51

1.04

4.25

0.052

0.88

0.70

1.01

71
Research Question 3
Is there an association between health care access and diabetic retinopathy among
adult African Americans in the United States?
Hо3: There is no association between health care access and diabetic retinopathy
among adult African Americans with DM in the United States.
H₁3: There is an association between health care access and diabetic retinopathy
among adult African Americans with DM in the United States.
α = .05
To address this question, a two-step complex samples logistic regression analysis
was conducted (Sperandei, 2014). The first step of the regression analysis was a reduced
model with the predictor variable of health care access and the dependent variable of
diabetic retinopathy. From the default predicted versus observed classification table in
SPSS, this regression model correctly classified participants 80.1% of the time. The
overall model for this step was not significant, x² (1) = 1.929, p = .178, Nagelkerke R² =
.010. The null hypothesis that there was no association between health care access and
diabetic retinopathy among adult African American populations in the United States was
not rejected. This model functioned as the model for comparison.
The second step of logistic regression analysis was full a full model with the
predictor variable of health care access, the dependent variable of diabetic retinopathy,
and all covariates of age groups, HBA1C level, UACR, marital status, education level,
and annual household income. This model correctly classified participants 81.0% of the
time; a statistically significant improvement over the comparison model was provided, x²
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(7) = 134.69, p <.001, Nagelkerke R² = .148. UACR and annual household income were
statistically significant. The null hypothesis that there was no association between the
combined predictor variables of health care access and the covariates and diabetic
retinopathy among adult African American populations in the United States was rejected.
However, health care access, the main variable of interest was not significant (p =
.178 and .177); the null hypothesis for Research Question 3 was not rejected. Table 10
displays the results of the comparison and full models for the logistic regression for the
association between health care access and diabetic retinopathy in African Americans.
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Table 10
Complex Samples Regression for the Association Between Health Care Access and Diabetic Retinopathy

Step

Variable

Wald x²

p

OR

95% CI for OR
Lower
Upper

1

Health care Access

1.93

.178

0.35

0.73

1.67

2

Health Care Access (ref: No
health care access)
HBAIC
Urine Albumin-Creatinine Ratio
Marital Status (ref: Married)
Annual Household Income (ref:
Less than $20,000)
Age Groups (ref: 60-80 years
old)
Adult Education Level (ref: Less
than High school Education)

1.96

.177

0.23

0.03

2.06

0.00
111.05
0.05
15.00

.992
.000
.828
.001

1.00
1.03
0.97
1.15

0.93
1.01
0.70
1.07

1.07
1.04
1.34
1.23

2.75

.112

0.75

0.52

1.08

3.94

.060

0.87

0.76

1.01
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Summary
There were three two-step complex samples logistic regression (reduced and
saturated models) conducted to address the three research questions. Null hypotheses for
Research Questions 1, 2, and 3 were not rejected because of the main predictor variables
of DM comorbidity of hypertension and hyperlipidemia, gender, and health care access,
respectively, were not significant. Covariates of UACR, annual household income, and
adult education level were statistically significant in Model 1; UACR and annual
household income were statistically significant in Models 2 and 3.
In the next section, I will discuss the implications of the results relative to similar
studies or publications. There will also be discussions on recommendations for the
professional practice among public health professionals, advocates, policymakers, and
clinicians, which should result in a positive social change with the reduction of physical,
mental, and socioeconomic burdens of diabetic retinopathy in African Americans.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
The purpose of this research was to examine associations between health
utilization factors of gender, DM comorbidities of hypertension and cholesterol, health
care access, and diabetic retinopathy among adult African Americans. In this section, the
research findings will be interpreted; I will also discuss the study limitations;
recommendations for the professional practice among clinicians and public health
professionals, advocates, and policymakers; implications for professional practice and
social change. The section ends with a conclusion. Data analyzed for this research were
from a nationally representative combined dataset of 2011-2012, 2013-2014, and 20152016 NHANES cycles. Descriptive and inferential data analysis of the final dataset was
performed with SPSS (Version 25), using the complex sample plan I developed to assure
correct data weighting that should lead to accurate findings representative of adult
African American population in the United States.
This study revealed a diabetic retinopathy prevalence of 21.5 % among the study
participants. Albuminuria, annual household income, and education level were
significantly associated with diabetic retinopathy.
Interpretation of the Findings
Prevalence of Diabetic Retinopathy
Diabetic retinopathy is the dependent variable for this study. More than one fifth
(21.5%) of the study participants and almost one fifth (19.5%) of study participants who
were 40 years and older were affected by diabetic retinopathy. Males (22.6%) were
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affected a little more than females (17.6%) (OR = 0.73 CL, 0.53 – 1.019). The overall
prevalence was lower than the result of previous research involving African Americans
For example, results of Zhang et al.’s (2010) cross-sectional study using data on a similar
population from the 2005-2008 NHANES cycles, showed almost two-fifths (38.8%, p =
.01) of African Americans had diabetic retinopathy. However, diabetic retinopathy was
diagnosed from ophthalmic digital images (fundus photographs) of participants taken for
the NHANES 2005–2008 cycles (Zhang et al., 2010).
Results of the current research suggested a decline in the prevalence of selfreported diabetic retinopathy, which is consistent with results of previous studies that
have shown a declining trend in the prevalence of self-reported diabetic retinopathy. For
example, Shah (2016), from a cross-sectional analysis of data from the NHANES 2011–
2012 and 2013–2014 cycles reported a decline in the prevalence of self-reported diabetic
retinopathy among U.S. adults, 40 years old and over, with a rate of 14.7% (95% CI,
11.7–17.8%). This represents a decline of 24.1% from the prevalence of 38.8% reported
by Zhang et al. Luo et al. (2018) reported a significant decrease of 33% (trend p = .003)
in the prevalence of self-reported diabetic retinopathy in North Carolina from 27.2% in
2000 to 18.3% in 2015; a decrease from 21.7% to 17.6% in Whites (trend p = .04), and a
decrease of 39.4% to 20.2% in African Americans (trend p = .002). Luo et al. used data
from the behavioral risk factor surveillance system (BRFSS). According to Luo et al.,
even though a declining trend in the prevalence of self-reported diabetic retinopathy was
observed, African Americans were still disproportionately affected.
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Research Question 1
Is there an association between gender and diabetes retinopathy among adult
African Americans in the United States?
The logistic regression models showed that the main independent variable,
gender, was not significantly associated with diabetic retinopathy in African Americans.
The result of this study is inconsistent with previous findings. However, after adjusting
for covariates, urine albumin-creatinine ratio (p < .001), annual household income (p =
.002), and adult education level (p < .048) were independently associated with diabetic
retinopathy in adult African Americans.
Results of the present study revealed that males (22.6%) were affected a little
more than females (17.6%; OR = 0.73 CL .53 – 1.019). Previous studies have not
established a consistent association between gender and development of diabetic
retinopathy; and in the United States, there is no significant gender-related difference in
the prevalence of diagnosed DM among adults (CDC, 2017; Ozawa et al., 2015; Wat et
al., 2016). For example, Varma et al. (2007) reported that males had a 50% higher risk of
having any diabetic retinopathy compared with women in the Los Angeles Latino eye
study (OR = 1.50; p = .006). Although the results of Zhang et al.’ (2010) study on a
representative sample of the U.S. population suggested that male gender is an
independent risk factor for diabetic retinopathy, the prevalence was higher among Whites
(59.7 %; 95% CI, 49.5%–69.1%) compared to African-Americans (24.0%; 95% Cl,
18.2%–30.8%; p = .008). Abdulghani et al. (2018) reported an association between male
gender and diabetic retinopathy in adult Saudi diabetic patients. However, results of a
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prospective diabetes study 50 in the United Kingdom showed no difference in diabetic
retinopathy rates between male and female sexes (p = 0.67), but it was a nonsignificant
association (Stratton et al., 2001).
Association between albuminuria and diabetic retinopathy in this study is
consistent with previous studies, as discussed under Research Question 1. Also, the
association between annual household income and education level, both components of
SES, and diabetic retinopathy is consistent with previous findings (Bird et al., 2015;
Emoto, Okajima, Sugihara, & Goto, 2016; Funakoshi et al., 2017; Hu et al.,2016; Kim et
al., 2018; Lee, 2018; Tao et al., 2016). The results of the current research will be
discussed in the last paragraph of this subsection because of their consistent relationship
with diabetic retinopathy concerning the three research questions.
Research Question 2
Is there an association between DM comorbidities of hypertension,
hyperlipidemia, and diabetic retinopathy among adult African American populations in
the United States?
The logistic regression showed no significant association between DM
comorbidity of hypertension and hyperlipidemia, the main variable of interest, and
diabetic retinopathy. However, after adjusting for covariates, UACR (p < .001) and
annual household income (p = .002) were independently associated with diabetic
retinopathy in African Americans. Research on the association between DM comorbidity
of hypertension and hyperlipidemia in African American populations is scarce. However,
the result of this present research is inconsistent with the findings of a previous study in
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China by Cheng et al. (2014) that depicted a significant association between diabetic
retinopathy prevalence and one, two, three, and four of the cardio-metabolites
(hypertension, hypertriglyceridemia, HDL, and abdominal obesity) of 16.0%, 17.6%,
21.3%, and 25.1%, (p = .001) respectively.
The presence of modifiable DM comorbidities of hypertension and
hyperlipidemia in individuals may not lead to complications. Hypertension exists when
systolic blood pressure is greater than or equal to 140 mmHg or diastolic blood pressure
is greater than or equal to 90 mmHg, or an individual is currently taking prescribed
medicine to lower high blood pressure or told by a healthcare professional on two or
more different visits that she/he had high blood pressure (American Heart Association,
2019). Normal systolic pressure is 120mmhg or below, and normal diastolic blood
pressure is 80mmhg or lower. Average total cholesterol level is less than 200mg/dL, LDL
is less than 100mg/dL, and HDL is 40mg/dL or higher (U.S. National Library of
Medicine [NIH], 2018). Hypertension and hyperlipidemia are fairly controlled among the
study participants.
Average measured systolic blood pressure of 134mmhg and HDL-cholesterol of
51.43 mg/dL suggest fairly controlled hypertension and hyperlipidemia among the study
participants. The nonsignificant association between diabetic retinopathy and diabetic
comorbidity of hypertension and hyperlipidemia in this study could have been caused by
the fairly controlled hypertension and hyperlipidemia among the study participants,
which is consistent with previous research findings. For example, a Cochrane review by
Do et al. (2015) showed that hypertension treatment could prevent diabetic retinopathy
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but does not slow its progression, and results of a Danish study by Nielsen and
Nordestgaard (2014) showed that use of statins before diagnosis of DM was associated
with decreased rate of retinopathy development; its use was also linked to improvement
in visual acuity in those with diagnosed diabetic retinopathy.
Complications such as diabetic retinopathy arise when hypertension and
hyperlipidemia are uncontrolled. Studies have shown that uncontrolled hypertension and
hyperlipidemia although modifiable, are major intermediate factors underlying macro and
microvascular disease such as diabetic retinopathy disparities of African American
populations (Beckman & Creager, 2016; Lin et al., 2015; Magnan et al., 2015;
Mozaffarian et al., 2016; Pantalone et al., 2015; Rosiek et al., 2016; Zhuo et al., 2014).
Papavasileiou et al. (2017) and Penman et al. (2016) reported that diabetic retinopathy in
African Americans is associated with longer duration of diabetes, uncontrolled
hyperglycemia, and hypertension. Nonsignificant association between DM comorbidity
of hypertension and hyperlipidemia may be related to their reasonably controlled levels.
For example, this present study revealed that for the composite variable of DM
comorbidity, 68.5% of study participants were informed they had high blood pressure
twice, and systolic high blood pressure was recorded on 35.7% of them. However,
average recorded systolic blood pressure was 134mmhg, and average diastolic pressure
69.80 mmHg (see Tables 5 and 6). Likewise, for the composite variable of
hyperlipidemia, 55.2% of participants reported taking cholesterol medications, and 18.5%
of them had low HDL; yet average total cholesterol was 181.46 mg/dl, direct HDL
cholesterol was 51.43 mg/dl, and LDL was 102.64 mg/dl (see Tables 5 and 6).
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Albuminuria (proteinuria) is a recognized marker of nephropathy (kidney
disease), and in patients with DM, it is a marker of diabetic nephropathy, which reflects
microvascular complications of diabetes that include diabetic retinopathy (ADA, 2018).
According to ADA, albuminuria can be detected by UACR screening in a spot urinalysis,
and UACR of less than 30 mg/g Cr is accepted as normal. Average UACR in this study
was 232.00 (SD = 687.14). Albuminuria and estimated glomerular filtration rate should
be monitored regularly in diabetic patients for (a) timely diagnosis of diabetic
nephropathy that may occur late in the course of DM, especially in individuals with Type
1 diabetics, or might be present at the time of diagnosis of Type 2 DM; (b) monitoring
diabetic nephropathy progression; and (c) detection of other kidney diseases such as acute
kidney injury that might be imposed on diabetic nephropathy (ADA). There is a paucity
of literature on the relationship between albuminuria and diabetic retinopathy among
African Americans.
The association between albuminuria and diabetic retinopathy in this study is
consistent with previous studies globally (Ahmed, Elwali, Awadalla, & Almobarak,
2017; Hammes et al., 2015; Jeng et al., 2016; Korlarsky et al., 2015; Lee et al., 2017;
Park et al., 2015). The results will be discussed fully at the end of this subsection because
of the consistency of the relationship between albuminuria and diabetic retinopathy
across the three research questions. The association between annual household income, a
component of SES, and nephropathy is also consistent with previous findings. Annual
household income is a component of SES. Results from the United States and other parts
of the world have also depicted the relationship between diabetic retinopathy and SES.
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The results from the present study will be discussed in the last paragraph in this
subsection because of their consistent relationship with diabetic retinopathy concerning
the three research questions.
Research Question 3
Is there an association between health care access and diabetic retinopathy among
adult African Americans in the United States?
The logistic regression models showed that the main independent variable, health
care access, was not significantly associated with diabetic retinopathy in African
Americans. However, after adjusting for covariates, UACR (p < .001) and annual
household income (p = .001), were independently associated with diabetic retinopathy
among adult African Americans. The result that health care access is not associated with
diabetic retinopathy is inconsistent with previous studies. For example, the results of
several studies showed that health care access is crucial to achieving control of
hyperglycemia, hypertension, and hyperlipidemia; early detection of diabetic retinopathy
through regular eye-screening of DM patients; and prompt management of diabetic
retinopathy that can prevent the development of early diabetic retinopathy and the
progression to the late stages (Atchison & Barkmeier, 2016; Chen et al., 2014; Chew et
al., 2014; Do et al., 2015; Lee et al., 2015; Lima et al., 2016; Mendanha et al., 2016;
Romero-Aroca et al., 2016; Ting et al., 2016; Wat et al., 2016).
Health care access involves getting into the health care system, which is
commonly through medical insurance coverage, geographic accessibility of required
health care services that include diabetes eye screening, and identifying a trustworthy
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health care provider that can be easily communicated with (Chou et al., 2014; Do et al.,
2015; Lee et al., 2015; Mendanha et al., 2016; Romero-Aroca et al., 2016; Wat et al.,
2016). The present study revealed that only 39.2% of the study population had access to
health care, lack of which could have affected their adequate management, including
regular eye screening for diabetic retinopathy. Relationship between disparities in
diabetes prevention services obtained and status of medical insurance during health care
facility visit was depicted by results of a retrospective cohort research by Bailey et al.
(2016); with lower odds (AOR=0.73, 95% CI = 0.66, 0.80) of receiving services at
scheduled visits in those that were continuously insured, compared to the continuously
uninsured patients. However, the internal and external validity of the results is
compromised by the purposive sampling method used and a predominantly Hispanic
population.
Results of a prospective follow-up study by Hu et al. (2016) depicted that
socioeconomic status is a stronger determinant of access to primary care and quality and
outcomes in those with T2DM than race and ethnicity. Bird et al. (2015) reported that
household income has a strong and independent association with the prevalence of T2DM
and some concordant comorbidities; however, African Americans were not included in
the study. Even though socioeconomic barriers were eliminated, there might be
difficulties in identifying a trustworthy health care provider that can be easily
communicated with, due to perceived racial discrimination.
Quality of health care service and the ability to identify a trusted health care
provider are related to racial health care discrimination. Racial and ethnic disparities exist
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in quality of care provided for control of chronic noncommunicable diseases such as
hypertension, hyperlipidemia, and diabetes that are risk factors for diabetic retinopathy,
with African-Americans and other minority patients having suboptimal control for blood
sugar, blood cholesterol, and blood pressure with resultant complications that include
diabetic retinopathy (Agency for Healthcare Research and Quality, 2017; Laiteerapong et
al., 2015; Yoon et al., 2015). According to Abramson et al. (2015), racial minorities,
especially African-Americans reported more racial health care discrimination; and
increased perceptions of discrimination were associated with poor communication with
health care provider across all racial and ethnic groups, and perceptions of discrimination
were associated with an increased level of education in all racial and ethnic groups except
Whites. Laiteerapong et al. (2015) carried out a cross-sectional study on a nationally
representative sample to determine disparities in diabetes care. The results showed that
more Whites achieved A1C < 8% goal than African Americans (81% versus 74%, p <
.001); fewer African Americans were recommended individualized LDL goals compared
to Whites (10% versus 33%, p < .003 ; more Whites (51%) achieved individualized LDL
control; and adequate blood pressure control goal of less than 140/90 mmHg was reached
by fewer African-Americans compared to Whites (53% versus 69% P < .001). Results of
a cross-sectional study by Assari et al. (2017) demonstrated that racial health care
discrimination is reported more by African American men with T2DM than women; and
perceived discrimination is associated higher levels of HBA1C in African American men.
Previous studies showed that even though African Americans are among those
that are disproportionately affected by diabetic retinopathy, they had one of the lowest
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rates of diabetic retinopathy screening and scheduled follow-up eye care utilization
(Keenum et al., 2016; Maclennan et al., 2014; Yu et al., 2015). Results of a prospective
follow-up study by Keenum et al. (2016) showed that despite minimizing accessibility
and costs as barriers to eye care, only a third of study participants adhered to scheduled
intervals for follow-up eye care after the diabetic retinopathy screening.
Association between albuminuria and diabetic retinopathy in this study is
consistent with previous studies, as discussed under research question 1. Also, the
association between annual household (a component of SES) and nephropathy is
consistent with previous findings. They are also consistent with findings in Research
Questions 1 and 2. The relationship between annual household income alone and as a
component of SES will be discussed in the last paragraph of this subsection.
Associations Between Albuminuria, Annual Household Income, Education Level,
and Diabetic Retinopathy in African Americans
The association between albuminuria and diabetic retinopathy in this study is
consistent across the three research questions in the current study and also with previous
studies globally (Ahmed et al., 2017; Hammes et al., 2015; Jeng et al., 2016; Korlarsky et
al., 2015; Lee et al., 2017; Park et al., 2015). For example, Lee et al. (2017) in South
Korea from a cross-sectional study reported an independent association between UACR
level and diabetic retinopathy and its severity in those with Type 2 DM. Results of a
cross-sectional study in South Korea by Park et al. (2015), showed that there was a
significant association between albuminuria and diabetic retinopathy and visionthreatening diabetic retinopathy in Type 2 diabetics with chronic kidney disease (p < .001
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and .043) respectively. Ahmed et al. (2017) in Sudan reported a significant association
between diabetic nephropathy and diabetic retinopathy (p = .009).
In Germany, microalbuminuria was independently associated with diabetic
retinopathy, and the strongest predictors of severe retinopathy were micro- and
macroalbuminuria and HbA1c (Hammes et al., 2015). Korlasky et al. (2014) in a
retrospective study carried out in southern Israel reported a unidirectional association
between diabetic nephropathy and diabetic retinopathy, with diabetic nephropathy
preceding diabetic retinopathy (p < .001) and level of kidney damage was proportionate
to the level of retinopathy. In Taiwan, Jeng et al. (2016) found that diabetic nephropathy
was an independent risk factor for diabetic retinopathy development and progression (p <
.001).
Associations between annual household income and education level, both
components of SES and nephropathy are consistent with previous findings. They are also
consistent with findings across the three research questions for the current study.
According to APA, SES refers to the social class of an individual or group that is
generally assessed by combining income, education, and occupation level (American
Psychological Association, 2019). SES creates health inequity and inequality, including
diabetic retinopathy that disproportionately affects disadvantaged groups such as the
African American population. Studies showed that even though African Americans are
among those are disproportionately affected by diabetic retinopathy, rates of diabetic
retinopathy screening and scheduled follow-up eye care utilization were lowest in this
population, which are related to limited health care access influenced by factors that
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include socioeconomic status (Hu et al., 2016; Keenum et al., 2016; Maclennan et al.,
2014; Piyasena et al., 2019; Yu et al., 2015).
In South Korea, the odds of developing diabetic retinopathy is significantly
decreased in men with highest household income (OR, 0.59; 95% CI, 0.37 - 0.95), while
men in lower SES group had higher odds of developing diabetic retinopathy and poor
metabolic control (Kim et al., 2018). In a cross-sectional study on Type 2 DM patients in
China, Tao et al. (2016) reported that those with the least education were at higher risk
for developing cardiovascular diseases such as diabetic retinopathy (p < .001) and
cerebrovascular diseases (p < .001); the highest prevalence of diabetic retinopathy (p <
.001), and diabetic neuropathy (p < .001) was among patients with the lowest income.
Among adults 20 - 40 years old with T2DM in Japan, when compared to those with a
higher SES, there were higher odds of developing retinopathy among junior high school
graduates (OR1.91, 95% CI 1.09 - 3.34); patients on public assistance (OR 2.19, 95% CI
1.20 - 3.95); patients without employment (OR 2.23, 95% CI 1.36 - 3.68); and patients
with temporary employment (OR 1.72, 95% CI 1.03 - 2.86) after adjusting for covariates
of gender, age, and BMI (Funakoshi et al., 2017). In South Korea, lower education level
was associated with lower diabetic retinopathy screening (Lee, 2018). Emoto et al. (2016)
reported that among individuals with poorly controlled Type 2 DM in Japan, there was a
strong association between lower educational attainment and diabetic retinopathy, which
is independent of the economic status.
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Limitations of the Study
This was a cross-sectional study that utilized data on a nationally representative
sample of adult African Americans with diabetes to examine the association between
diabetic retinopathy and diabetes comorbidities of hypertension and hyperlipidemia,
gender, health care access, and covariates (UACR, annual household income, age, marital
status, HBA1C, and education level). However, there are some limitations to the study.
Study participants for NHANES were only noninstitutionalized legal residents in the 50
states and the District of Colombia; as such the results of this research may not be
generalizable to those that did not qualify for inclusion in the survey (CDC, 2017a). The
prevalence of diabetic retinopathy in this study could have been inaccurate because it was
based on data from self-reported diagnosis, which could have resulted in recall bias due
to inaccurate or incomplete recollections of past events or experiences, thus affecting the
prevalence. Also, self-reported diagnosis without fundus photography of participants in
2011-2012, 2013-2014, and 2015-2016 NHANES cycles compared to 2005-2008
NHANES cycle could have underestimated the prevalence of diabetic retinopathy in this
study.
As a cross-sectional study, the relationships between the dependent variable of
diabetic retinopathy and the independent variables were examined in a specified
population within a specific timeframe; the association between diabetic retinopathy and
the identified risk factors of albuminuria, annual house income, and education level were
demonstrated. There was no indication of the order of events, limiting inference of cause
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and effect (Caruana et al., 2015; Mariani & Pego-Fernandes, 2014; Omair, 2015; Setia,
2016).
Recommendations
This cross-sectional study examined the relationships between the dependent
variable of diabetic retinopathy and the independent variables that were in a specified
population with a specific timeframe. Risk factors for diabetic retinopathy such as
albuminuria, annual house income, and education level were identified, but cause and
effect from simple association could not be established from the type of study design that
was utilized. There is a paucity of literature on studies that established the identified risk
factors as causes of diabetic retinopathy in adult African Americans. I recommend that
the associations identified in the present study should be studied rigorously by utilizing
longitudinal study designs to establish cause and effect (Mariani & Pego-Fernandes,
2014; Setia, 2016).
Prevalence of diabetic retinopathy in this study was based on data from selfreported diagnosis that could resulted in recall bias due to inaccurate or incomplete
recollections of past events or experiences, which could have affected the prevalence.
Self-reported diagnosis without fundus photography of participants in 2011-2012, 20132014, and 2015-2016 NHANES cycles compared to 2005-2008 NHANES cycle could
have underestimated the prevalence of diabetic retinopathy in this study. Prevalence of
diabetic retinopathy in all adults in this study was 21.5% and 19.5% in those 40 years and
older, similar to 14.7% reported by Luo et al. (2018), suggesting a decline in the
prevalence of self-reported diabetic retinopathy. The prevalence is lower than the result
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of similar research by Zhang et al. (2010) that utilized digital retinal imaging system to
assess the retina, with a prevalence rate of 38.8% among adults 40 years. I recommend
the use of fundus digital imaging system photographs in assessing the retina of future
NHANES participants, thus eliminating the recall bias associated with a self-reported
diagnosis of diabetic retinopathy (Katulanda, Ranasinghe, & Jayawardena, 2014).
Implications for Professional Practice and Social Change
In this cross-sectional study, albuminuria, annual household income, and
education level were identified as risk factors for diabetic retinopathy. Albuminuria (need
factor), education level (predisposing factor), and annual household income (health care
access factor) were identified as risk factors for diabetic retinopathy that affects about
one-fifth of adult African Americans. The Andersen model of health care utilization was
the framework for the research. Diabetic retinopathy is a significant cause of preventable
eye damage that includes blindness; each year, between 12,000 and 24,000 new cases of
blindness are caused by diabetes retinopathy (Skaggs et al., 2017).
The vision-threatening diabetic retinopathy, although a preventable complication
of DM, is associated with disease, economic, health care system, and social burdens.
Quality of life of persons with any degree of moderate or total visual loss is affected in
many ways such as their psychological and physical well-being, their work and possible
loss of earning power, social integration, independence, and greater need for quality
health and social support that could be overwhelmed in disadvantaged communities that
include some African American communities where such services barely exist
(International Diabetes Federation, n.d.; Skaggs et al., 2017; Willis et al., 2017). Early
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detection of diabetic retinopathy is crucial in preventing visual impairment; and
progression of diabetic retinopathy has been dramatically reduced by timely medical and
surgical treatments (Jani et al., 2017).
Even though African Americans are among those disproportionately affected by
diabetic retinopathy, rates of diabetic retinopathy screening and scheduled follow-up eye
care utilization were lowest in this population, which are related to limited health care
access influenced by factors that include socioeconomic status (Hu et al., 2016; Keenum
et al., 2016; Maclennan et al., 2014; Piyasena et al., 2019; Yu et al., 2015). SES creates
health inequity and inequality which can only be addressed by interventions that target
the societal determinants of health, developed and implemented by considering the
broader, proximal, population-focused determinants that influence health inequalities and
inequities among African Americans (Gehlert et al, 2008; Thornton et al., 2016; U.S.
Department of Health and Human Services, 2010; WHO, 2016).
Positive social change can be affected in African American populations and other
disadvantaged communities by public health officials, policymakers, and advocates by
utilizing knowledge on the strong relationships between the health care utilization factors
(need, predisposing, and enabling factors) and diabetic retinopathy in planning and
developing effective public health interventions targeting these communities. This should
result in a decreased burden of diabetic retinopathy on individuals, families and friends,
health care systems, and social support systems among specific African American
populations and other disadvantaged communities. Suggested policy interventions
include quality housing and health services, elimination of health discrimination,
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improvement in education, and reduction in income disparity in some African American
populations and other disadvantaged communities (Thornton et al., 2016).
Conclusion
This study investigated the associations between DM comorbidities of
hypertension and hyperlipidemia (need factor), gender (predisposing factor), health
access (enabling factor), and diabetic retinopathy in adult African Americans. The results
demonstrated that DM comorbidities, gender, and health care access were not
significantly associated with diabetic retinopathy. However, albuminuria (need factor),
education level (predisposing factor), and household income (enabling factor) were
significantly associated with diabetic retinopathy. These variables may be central to
future studies to determine cause and effect relationships between diabetic retinopathy
and the determinants of health care utilization among adult African Americans with DM.
The result of this study is consistent with those of previous studies, which
depicted that albuminuria, annual household income, and education level are risk factors
for diabetic retinopathy among different racial groups. As such, it is crucial to consider
the need, predisposing, and enabling factors that determine health care utilization and
detection of diabetic retinopathy when planning public health intervention policies
targeting disadvantaged populations.
Chronic diseases such as DM, hypertension, and hyperlipidemia are modifiable
risk factors for developing macro- and microvascular diseases such as diabetic
retinopathy and nephropathy with their often-burdensome end stages that
disproportionately affect African Americans and other disadvantaged racial and ethnic
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groups. The socioeconomic and health disparities can be reduced by public health
advocates and policymakers developing policy interventions that address the
socioeconomic drivers of health inequalities and inequities among African Americans
and other disadvantaged racial and ethnic groups, and communities.
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